hg_194982.1

Basic information about the TSS

---

TSS ID: hg_194982.1 Species: human Chr: chrM		Start: 12413 End: 12427 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000361567.2 uc004cox.6 AF339085 AF339086 Distance: -77 GeneID: 4540 HGNC/MGI_ID: HGNC:7461 UniProt_ID: U5ZC31

Gene_name: mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 Gene_symbol: MT-ND5 Gene_synonyms: NAD5 ND5 Gene_source: HGNC:7461

TATA-Box annotation

---

Distance to TSS:	10749
Nearest PromoterID:	NR_137295
Entrez ID:
Nearest Unigene:
Nearest Refseq:
Nearest Ensembl:
Gene Name:	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5
Gene Alias:
Gene Description:
Gene Type:
CpG%:	0.01
GC%:	0.402985
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MT-ND5 p2@MT-ND5 p3@MT-ND5 p4@MT-ND5 p5@MT-ND5
Sample		p1@MT-ND5	p2@MT-ND5	p3@MT-ND5	p4@MT-ND5	p5@MT-ND5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	1603.04	43.05	30.00	10.32	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	2464.64	63.12	50.78	14.57	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	2780.52	80.25	66.94	18.13	2.51
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1958.31	63.41	42.83	13.10	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1761.93	56.92	52.42	8.10	2.02
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	2381.35	71.52	62.41	14.15	3.49
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	3573.94	97.18	89.77	33.12	3.70
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1712.73	47.23	45.78	10.42	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1721.27	50.86	37.83	12.40	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1506.45	77.09	51.01	14.49	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	2137.19	86.91	42.04	15.36	4.04
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	1118.83	46.35	40.66	9.35	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	1739.11	61.58	55.77	14.67	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	1375.85	55.93	46.01	13.98	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	1063.52	45.01	37.54	10.54	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	1847.95	89.78	69.66	17.35	4.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	1661.42	65.30	50.67	19.44	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	3864.69	168.73	108.41	39.23	5.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	1810.06	87.97	46.92	21.86	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	1075.06	64.09	52.65	17.30	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	1957.47	79.26	62.95	25.13	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	1425.18	59.56	68.19	19.33	4.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	1420.28	57.78	50.28	16.29	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	1797.68	75.23	69.89	13.83	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	1624.56	72.50	62.95	14.71	3.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	1778.16	71.22	59.82	21.52	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	3145.11	125.83	94.51	37.91	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	3040.98	96.42	53.75	28.29	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	1535.44	66.55	46.20	19.87	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	977.03	45.78	39.45	9.59	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	1366.18	67.20	51.29	17.58	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	1479.43	70.53	41.81	13.68	4.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	4006.39	174.52	102.98	43.89	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	1988.51	90.55	47.67	24.58	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	1282.38	61.71	40.02	18.14	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	1397.70	57.49	37.37	16.67	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	1596.00	65.61	46.80	15.74	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	832.95	40.50	33.25	10.88	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	1518.25	63.74	44.03	14.59	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	1114.85	50.17	39.37	12.00	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	1280.99	47.29	36.70	11.06	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	1614.44	64.71	35.72	19.76	2.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	900.94	44.92	29.31	8.44	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	1680.61	68.71	42.83	16.78	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	955.08	41.96	29.71	7.83	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	1703.20	67.00	46.99	17.22	3.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	1162.83	46.06	27.83	9.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	1441.67	56.33	39.94	12.82	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	1249.05	47.40	36.86	10.29	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	1218.44	39.23	29.72	9.91	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	1724.89	97.15	55.54	20.09	5.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	3474.60	135.43	68.27	28.46	7.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	30950.71	713.60	209.88	181.90	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	1448.18	80.55	43.65	15.26	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	812.22	53.02	39.10	9.61	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	32116.20	343.96	145.14	213.09	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5758.43	198.85	76.69	69.80	6.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	822.91	56.39	40.51	9.08	3.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1793.73	84.15	50.42	13.49	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	3758.76	119.45	88.33	35.83	8.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	938.43	42.30	36.66	9.17	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	880.44	47.67	40.38	12.34	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	17816.08	246.80	181.52	117.83	21.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4697.63	147.46	84.26	36.36	9.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	1556.05	90.33	82.85	19.17	4.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	1562.62	91.94	50.05	14.55	4.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	28674.82	355.61	290.95	161.64	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	28201.90	481.75	205.33	118.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	1029.63	67.76	31.20	7.31	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	677.36	47.11	38.68	7.93	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	633.30	35.65	24.39	4.22	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	1484.06	59.61	33.78	11.59	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	606.93	37.74	30.32	9.59	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	754.58	42.50	27.52	13.15	0.92
Adipocyte - breast, donor1	11376-118A8	478.32	19.48	8.87	6.02	0.16
Adipocyte - breast, donor2	11327-117E4	2153.41	77.00	26.31	22.46	1.76
Adipocyte - omental, donor1	11473-119C6	480.16	9.41	6.49	5.09	0.51
Adipocyte - omental, donor2	11474-119C7	883.54	51.58	2.99	11.96	0.75
Adipocyte - omental, donor3	11475-119C8	748.54	43.87	3.68	13.40	0.33
Adipocyte - perirenal, donor1	11476-119C9	530.17	26.80	5.74	6.38	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	295.77	9.90	2.20	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	657.57	18.06	4.97	8.58	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	1047.35	26.76	8.17	9.21	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	349.29	8.21	5.67	3.52	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	298.82	9.52	4.12	3.86	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	321.70	9.20	4.46	4.74	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	296.26	13.52	8.23	6.47	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	899.16	25.74	9.41	10.94	1.85
Adipocyte differentiation, day08, donor2	13023-139D8	489.94	21.95	12.26	9.04	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	438.81	23.46	11.73	8.00	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	535.29	17.81	5.56	6.68	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	749.44	18.72	5.82	5.41	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	612.84	19.84	10.05	5.78	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	559.26	16.04	9.49	4.91	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	407.69	17.66	11.27	3.04	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	457.47	6.19	5.08	1.33	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	452.53	12.55	0.00	5.74	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	346.23	4.79	2.40	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	573.72	13.13	3.60	4.32	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	575.68	8.37	8.37	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	351.93	8.22	4.93	2.47	0.62
Anulus Pulposus Cell, donor1	11248-116E6	159.17	3.32	4.58	0.69	0.11
Anulus Pulposus Cell, donor2	11463-119B5	217.72	6.12	0.00	1.96	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	1040.57	40.44	15.73	14.38	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	1395.33	42.55	6.95	16.06	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	1412.56	89.89	55.65	34.24	14.98
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	966.12	40.65	13.15	14.35	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1187.51	31.62	11.38	15.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	502.97	21.12	9.90	5.28	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	772.58	19.49	8.77	5.85	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	991.27	27.18	11.17	10.19	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	722.75	29.10	17.22	10.69	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	749.88	19.96	9.79	13.18	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	987.64	25.40	13.79	8.71	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	816.21	30.09	18.81	6.27	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	256.00	3.62	2.31	1.15	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1063.18	20.47	17.74	12.28	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	327.67	6.63	5.43	1.51	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	884.58	26.79	2.68	8.57	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	522.60	16.82	7.56	7.37	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	622.78	15.50	10.96	6.68	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	987.16	28.29	13.66	21.46	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	403.37	12.11	5.81	5.47	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	456.27	21.61	10.81	8.41	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	630.15	24.78	3.54	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	713.05	19.21	8.58	6.35	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	490.81	16.78	4.19	0.00	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	869.40	31.55	7.77	16.02	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	473.18	17.08	6.07	5.69	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1092.65	38.76	15.75	20.59	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	624.19	17.10	9.12	9.12	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	559.66	18.17	5.56	5.99	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	443.14	9.29	8.26	2.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	922.93	25.34	10.79	15.48	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	897.77	22.83	10.61	9.32	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	336.04	13.56	7.13	3.57	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	972.77	22.81	13.45	12.87	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	647.00	18.37	4.82	6.92	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	893.37	35.64	27.32	7.13	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	915.41	37.12	13.22	14.24	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	1158.83	37.69	19.10	15.28	2.04
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	278.29	13.34	7.62	6.35	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	805.67	25.03	11.22	10.79	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	524.77	16.51	8.47	7.83	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	428.59	9.86	10.15	5.22	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	1183.75	43.46	12.28	19.84	4.72
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	472.13	11.02	5.09	5.76	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	938.13	34.75	18.53	11.58	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	992.91	52.81	6.34	12.68	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	524.02	15.22	4.07	6.22	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	336.33	6.62	10.83	4.21	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	687.43	22.60	6.56	10.21	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	495.85	18.39	6.90	6.90	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2830.83	96.91	63.76	25.50	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	369.40	4.83	7.37	1.27	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	615.19	14.04	7.02	7.84	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	651.17	13.16	11.63	6.12	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	846.56	29.16	10.52	12.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	621.09	15.08	7.10	5.54	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	555.39	28.99	15.26	4.58	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	603.18	13.29	4.98	4.98	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	556.60	18.27	4.77	5.56	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	497.92	12.72	9.45	5.45	0.73
Astrocyte - cerebellum, donor1	11500-119F6	427.89	6.51	1.35	2.09	0.37
Astrocyte - cerebellum, donor2	11580-120F5	434.92	14.89	1.20	7.19	0.00
Astrocyte - cerebellum, donor3	11661-122F5	311.06	5.87	4.19	1.89	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	534.73	16.38	11.50	3.83	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	1214.27	30.90	18.44	10.19	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	703.89	12.08	8.65	6.12	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	2611.62	64.68	39.22	27.30	3.44
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	2850.41	51.62	37.21	25.31	2.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2594.90	54.39	35.96	24.01	2.96
Basophils, donor1	12241-129G9	133.64	4.71	2.35	2.09	0.52
Basophils, donor2	12242-129H1	151.17	4.33	1.44	2.53	0.36
Basophils, donor3	12243-129H2	161.26	4.85	2.06	1.91	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	643.36	15.52	6.25	4.10	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	651.49	22.86	4.11	7.31	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	1040.17	50.21	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	71.55	7.53	0.00	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	150.97	7.69	1.04	4.16	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	418.21	12.21	2.30	4.61	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	1675.47	26.99	16.38	13.86	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	1605.50	1.75	26.18	2.37	1.44
Burkitt's lymphoma cell line:RAJI	10476-106I8	3637.96	80.82	47.98	27.95	3.96
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	207.53	3.52	4.48	0.96	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	361.97	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	417.59	9.02	5.07	4.51	1.13
CD14+ Monocytes, donor2	11305-117B9	1568.88	28.58	8.91	12.81	0.74
CD14+ Monocytes, donor3	11381-118B4	1375.62	27.44	14.49	13.17	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	378.43	11.89	10.76	5.38	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	352.16	11.37	10.24	4.17	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	255.43	11.51	2.96	3.29	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	578.63	22.55	10.70	9.11	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	387.14	14.18	4.83	5.43	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	359.37	13.98	6.63	4.50	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	534.17	18.08	7.37	8.04	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	574.10	16.56	6.07	5.52	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	509.74	17.60	4.71	5.95	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	567.23	17.82	8.22	6.85	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	383.69	14.78	5.70	5.52	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	342.55	8.27	3.26	5.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	503.37	14.75	5.15	5.62	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	748.74	13.20	4.22	6.34	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	704.44	6.66	3.33	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	892.64	30.79	9.97	10.41	1.78
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	484.50	13.17	7.18	5.39	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	305.64	8.95	2.29	3.54	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	618.18	16.24	8.01	9.38	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	306.96	9.27	3.85	2.94	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	594.90	17.89	6.55	5.67	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	292.66	15.60	6.72	4.30	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	757.68	23.55	9.94	7.33	1.40
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	685.52	16.83	5.05	8.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1618.31	42.07	15.06	16.35	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	472.39	15.85	3.52	5.28	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	512.87	15.79	6.58	8.34	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1053.57	34.87	13.08	13.08	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1946.47	36.42	15.61	11.89	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	412.56	9.70	4.53	1.51	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1038.87	33.17	21.29	13.92	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	290.44	9.27	4.17	4.64	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	307.62	8.58	3.94	2.55	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	633.84	7.63	2.83	2.83	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	759.74	9.70	3.93	3.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	469.41	5.20	2.17	3.03	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	614.79	9.97	5.76	3.74	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	527.43	6.46	5.24	3.14	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	1513.51	25.86	7.80	6.91	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	295.75	4.59	1.28	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	599.63	9.44	4.17	1.76	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	430.57	7.58	3.37	2.74	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	298.75	2.03	6.10	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	406.11	6.78	5.42	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	402.85	5.18	4.14	6.21	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	465.88	10.13	13.33	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	449.22	10.19	5.36	3.75	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	284.29	4.21	2.81	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	218.05	3.14	4.71	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	326.93	6.59	0.00	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	2444.33	69.86	36.16	22.19	6.58
CD19+ B Cells, donor2	11624-122B4	2336.60	59.49	33.37	18.86	2.90
CD19+ B Cells, donor3	11705-123B4	1515.99	42.41	19.69	16.15	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1120.45	12.12	14.95	5.66	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	390.30	3.99	5.99	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	122.49	2.01	2.01	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	220.23	3.37	5.06	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	836.81	18.04	9.77	4.88	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	485.01	6.99	4.51	1.58	0.45
CD4+ T Cells, donor1	11225-116C1	859.79	21.07	14.28	7.50	1.43
CD4+ T Cells, donor2	11306-117C1	2489.26	61.24	28.17	21.43	1.84
CD4+ T Cells, donor3	11382-118B5	2123.97	43.31	15.55	17.38	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	700.88	11.74	4.34	2.81	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	905.58	11.01	6.96	2.92	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	576.07	12.07	4.31	3.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	453.23	9.48	5.69	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	620.15	8.43	2.81	1.40	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	972.39	26.37	3.30	16.48	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	477.05	8.24	3.61	2.46	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	1355.70	23.72	13.73	9.15	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	920.97	20.96	16.44	4.35	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	646.00	9.41	6.28	2.24	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	486.00	7.69	2.80	2.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1458.10	14.96	6.16	7.92	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	898.94	12.65	4.22	4.22	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	1137.12	21.19	15.58	7.48	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	698.66	18.04	8.02	6.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1300.39	14.96	9.79	5.98	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1071.36	15.54	6.97	4.82	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1416.65	25.11	14.35	14.35	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	643.99	11.50	5.75	4.08	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	938.60	6.93	3.68	2.38	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	411.48	7.36	3.57	1.68	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	391.34	9.61	3.54	3.03	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	386.03	8.23	4.33	5.20	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	2138.98	18.30	8.28	9.15	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	451.82	11.88	4.95	2.97	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	449.59	6.46	0.92	7.39	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	297.31	2.79	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	247.30	6.37	0.83	1.38	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	634.09	16.20	1.47	7.61	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	389.62	4.62	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	301.18	5.01	1.79	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	185.59	1.38	2.77	0.00	4.15
CD8+ T Cells, donor1	11226-116C2	672.47	21.61	14.73	5.89	0.98
CD8+ T Cells, donor2	11307-117C2	2008.94	48.81	25.53	13.89	2.25
CD8+ T Cells, donor3	11383-118B6	2760.46	54.29	31.06	22.98	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4720.65	93.36	44.96	20.42	2.29
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6932.14	149.54	72.37	34.99	1.68
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6382.07	112.72	76.88	29.27	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3542.49	58.54	45.03	19.21	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4833.01	108.71	33.12	24.96	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2712.48	64.35	40.25	13.42	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3364.43	68.44	44.98	14.78	2.17
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2579.93	48.43	30.53	15.27	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3219.19	76.69	30.96	19.46	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5641.48	117.13	53.43	25.06	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4232.07	81.05	58.10	20.04	3.49
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2183.96	46.36	31.17	11.46	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	853.18	29.77	39.40	5.25	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	744.17	25.50	27.33	7.29	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	985.30	34.31	45.50	8.20	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1938.00	40.34	16.57	9.36	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2667.47	52.65	25.32	13.24	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1907.73	40.78	22.39	11.55	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	4187.25	84.30	24.72	16.48	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2756.38	52.90	19.07	10.15	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	2379.37	50.65	23.40	11.86	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3124.36	66.55	30.21	13.77	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3014.11	64.24	23.25	17.34	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4658.75	109.68	37.06	21.94	6.81
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	2980.57	81.90	70.66	16.86	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	3325.08	83.93	77.64	26.58	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	6315.04	135.24	88.15	26.05	1.00
Cardiac Myocyte, donor1	11525-119I4	1712.59	60.32	23.76	16.45	1.83
Cardiac Myocyte, donor2	11605-120I3	489.15	12.85	7.41	3.95	0.00
Cardiac Myocyte, donor3	11686-122I3	91.97	2.10	0.95	0.42	0.00
Chondrocyte - de diff, donor1	11261-116G1	1862.99	37.79	1.73	8.67	0.00
Chondrocyte - de diff, donor2	11338-117F6	394.47	13.86	4.26	3.55	0.36
Chondrocyte - de diff, donor3	11410-118E6	1018.21	17.86	9.44	8.53	0.11
Chondrocyte - re diff, donor2	11339-117F7	638.32	38.50	6.27	8.06	2.69
Chondrocyte - re diff, donor3	11411-118E7	822.56	22.24	10.92	5.66	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	503.44	12.51	8.03	5.28	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	1048.95	26.93	14.96	15.18	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	1134.98	26.81	14.16	12.66	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	2352.85	57.68	30.35	26.78	2.02
Corneal Epithelial Cells, donor1	11526-119I5	429.70	12.08	5.49	4.61	0.22
Corneal Epithelial Cells, donor2	11606-120I4	1044.32	35.27	13.65	5.69	2.28
Corneal Epithelial Cells, donor3	11687-122I4	492.09	10.23	6.90	4.35	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	252.60	11.89	6.77	4.62	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	347.27	13.25	15.77	5.36	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	690.14	20.70	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	960.46	28.62	18.90	9.40	1.73
Dendritic Cells - plasmacytoid, donor1	11228-116C4	323.19	7.86	7.17	6.49	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	101.85	0.65	1.96	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	150.51	2.42	0.48	2.90	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	272.83	9.01	3.00	3.50	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	140.83	8.21	19.36	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	535.34	13.29	6.22	6.79	2.55
Endothelial Cells - Aortic, donor3	11412-118E8	379.03	8.65	2.36	3.93	1.97
Endothelial Cells - Artery, donor1	11264-116G4	305.42	6.11	3.49	3.20	0.58
Endothelial Cells - Artery, donor2	11341-117F9	341.86	13.18	4.94	3.76	0.47
Endothelial Cells - Artery, donor3	11413-118E9	197.92	5.61	1.93	1.40	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	375.04	10.86	10.20	3.55	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	469.18	5.78	5.17	1.83	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	612.29	10.71	6.20	5.07	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	216.02	5.65	1.49	1.78	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	271.79	9.37	1.56	2.08	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	444.36	11.63	3.97	2.98	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	311.69	9.60	0.40	4.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	321.81	6.81	3.14	4.72	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	581.72	13.54	7.95	5.96	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	380.64	15.86	6.08	5.87	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	525.76	12.33	6.96	6.23	1.10
Endothelial Cells - Vein, donor1	11267-116G7	97.83	4.55	6.83	3.41	1.14
Endothelial Cells - Vein, donor2	11344-117G3	348.55	9.78	2.79	3.49	1.40
Endothelial Cells - Vein, donor3	11416-118F3	462.23	9.58	5.65	5.18	0.31
Eosinophils, donor1	12244-129H3	228.70	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	51.16	1.65	4.95	0.00	0.00
Eosinophils, donor3	12246-129H5	74.90	10.70	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	580.27	11.48	5.38	2.93	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	493.00	16.64	0.00	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	780.90	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	606.74	18.88	14.37	9.85	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	411.24	19.82	13.03	6.35	2.30
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.61	0.87	0.65	0.43	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	563.83	8.73	7.64	4.24	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	446.26	7.23	3.68	2.73	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	845.86	22.25	6.86	8.02	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	3855.13	88.80	8.17	30.83	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	1361.02	36.87	13.95	13.62	0.33
Fibroblast - Cardiac, donor1	11268-116G8	226.36	5.44	4.54	1.81	0.91
Fibroblast - Cardiac, donor2	11345-117G4	415.36	6.82	5.31	6.82	0.76
Fibroblast - Cardiac, donor3	11417-118F4	424.10	7.89	4.42	3.94	0.16
Fibroblast - Cardiac, donor4	11452-119A3	188.84	0.91	2.12	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	313.33	13.45	2.66	5.46	0.13
Fibroblast - Cardiac, donor6	11460-119B2	297.12	1.67	4.40	2.43	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	318.76	7.91	0.27	3.48	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	399.50	15.96	7.77	5.61	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	2312.91	36.62	13.18	16.11	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	484.80	8.99	3.00	2.77	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	620.75	5.43	6.44	1.70	0.17
Fibroblast - Dermal, donor1	11269-116G9	548.45	11.27	4.46	3.76	0.47
Fibroblast - Dermal, donor2	11346-117G5	425.45	14.15	14.15	2.36	1.42
Fibroblast - Dermal, donor3	11418-118F5	1703.65	26.96	18.98	12.69	1.09
Fibroblast - Dermal, donor4	11450-119A1	156.91	7.69	1.13	3.28	0.45
Fibroblast - Dermal, donor5	11454-119A5	268.83	13.08	1.40	6.28	0.17
Fibroblast - Dermal, donor6	11458-119A9	308.28	11.37	1.95	5.36	0.16
Fibroblast - Gingival, donor1	11237-116D4	327.34	9.58	5.62	3.33	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	585.31	5.76	4.72	3.93	0.52
Fibroblast - Gingival, donor2	11318-117D4	1159.04	24.12	11.07	9.88	0.79
Fibroblast - Gingival, donor3	11394-118C8	499.68	8.32	4.83	4.06	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	203.62	6.23	3.12	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	693.01	23.26	9.34	9.34	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	1034.68	19.80	16.99	5.92	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	1174.99	19.74	11.76	5.95	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	641.53	17.29	3.53	2.82	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	810.49	13.89	9.21	4.24	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	1459.39	18.82	12.41	9.95	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	831.58	13.05	9.10	4.17	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	701.56	23.48	15.11	7.78	1.03
Fibroblast - Lung, donor1	11270-116H1	191.67	0.00	4.08	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	1959.20	29.84	28.35	11.94	0.00
Fibroblast - Lung, donor3	11419-118F6	211.04	3.80	2.95	1.27	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	583.12	10.00	1.67	4.17	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	303.50	11.19	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	241.81	4.76	3.64	1.40	0.00
Fibroblast - Mammary, donor1	11540-120B1	338.17	4.87	2.03	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	475.31	3.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	583.71	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	561.55	12.80	7.76	4.66	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	1016.57	22.90	14.86	9.40	1.97
Fibroblast - Periodontal Ligament, donor3	11395-118C9	314.25	3.37	3.98	3.98	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	164.10	9.92	1.53	2.29	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	454.66	12.42	9.18	6.48	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	247.37	11.02	4.87	4.18	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	193.98	3.32	2.21	1.33	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	329.37	7.92	2.44	1.63	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	358.83	9.35	5.35	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	211.91	3.56	1.19	1.58	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	206.39	4.76	0.20	1.19	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	860.21	11.90	5.33	5.15	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	938.52	15.37	8.87	5.72	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	2293.72	61.98	7.22	24.37	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	539.43	12.85	1.62	5.18	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	85.54	2.28	0.25	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	643.19	11.81	4.43	3.61	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	3260.65	90.23	32.88	25.87	2.21
Fibroblast - skin normal, donor2	11561-120D4	375.73	8.44	1.00	2.71	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	112.13	3.32	0.00	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	327.32	6.13	4.89	2.24	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	682.26	1.20	2.91	1.88	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	2804.15	71.60	9.85	27.92	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	503.10	11.72	1.17	4.37	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	648.07	12.48	6.75	4.72	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	1730.19	40.15	28.85	16.15	3.61
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1927.90	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	878.50	27.89	7.84	10.46	5.23
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	241.14	9.71	3.81	1.91	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	605.58	15.61	7.29	3.90	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	228.68	7.92	2.81	2.30	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	557.32	26.79	8.42	5.36	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	791.21	22.97	18.50	4.47	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	3436.29	79.59	59.05	31.95	3.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1711.63	52.12	38.33	17.92	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	1322.92	32.88	17.12	13.01	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	2669.21	63.80	37.05	19.42	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1638.08	42.56	30.13	14.54	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	781.12	23.16	9.78	6.52	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	6693.06	102.60	55.28	41.57	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	453.36	12.44	4.10	4.24	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	551.68	12.68	4.31	5.17	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	853.96	18.80	9.94	7.79	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	490.25	14.50	3.96	4.21	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	553.01	9.14	5.12	4.01	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	543.63	13.82	6.71	4.47	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	538.50	14.15	6.85	6.85	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	551.95	9.84	4.11	3.74	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	408.52	15.52	5.25	4.37	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	588.30	17.73	8.86	6.80	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	798.61	16.85	5.40	5.88	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	492.86	11.84	2.68	4.47	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	810.77	21.17	6.25	6.65	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	761.18	13.91	4.24	6.28	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	452.94	14.72	5.59	4.43	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	456.39	25.81	7.60	9.78	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	370.76	18.79	3.07	3.42	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	502.59	11.51	3.76	5.31	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	414.57	12.48	5.24	4.49	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	358.13	11.64	3.68	2.65	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	581.16	17.74	6.81	3.09	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	735.57	16.72	3.57	5.30	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	674.23	23.35	7.17	8.34	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	839.18	19.84	11.24	5.29	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	715.32	16.85	6.15	5.90	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	971.58	18.48	6.65	6.16	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	1073.75	22.13	9.30	10.58	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	639.78	14.78	5.21	7.49	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	671.93	14.24	6.33	5.06	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	933.55	32.84	7.30	6.69	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	739.19	18.50	5.33	6.90	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	700.82	15.59	6.59	5.05	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	956.67	25.53	8.98	11.22	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	411.83	15.83	4.07	6.02	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	821.73	17.92	8.02	5.62	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	657.31	18.21	8.42	5.97	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	683.83	12.69	3.76	5.05	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	782.05	13.01	7.32	4.34	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	1146.11	25.99	10.14	8.11	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	975.28	20.83	10.31	6.80	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	3133.92	58.51	30.74	7.93	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	695.18	16.09	6.46	4.35	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	707.36	16.54	9.08	7.47	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	1212.09	33.04	16.52	10.93	3.05
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	946.13	24.88	2.19	8.36	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	895.95	19.72	7.55	9.24	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1009.21	23.53	6.75	8.18	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	396.48	0.63	8.45	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	224.07	0.28	2.54	0.85	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1538.12	4.61	32.28	6.00	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1442.81	4.95	7.42	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	979.40	1.93	15.47	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1753.68	1.60	20.86	3.21	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1530.17	3.48	33.04	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	759.67	3.25	17.25	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1547.96	3.29	27.18	6.18	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	9560.28	26.66	103.30	16.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	932.35	4.47	16.50	1.68	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1104.73	2.29	16.34	2.94	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	4429.06	4.19	56.20	9.23	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1026.74	3.50	17.81	2.23	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	686.46	2.38	8.49	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	628.53	4.18	14.62	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	633.41	1.72	6.30	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	426.81	0.59	10.06	0.89	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	2852.94	5.08	28.80	8.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	893.45	2.07	19.47	1.24	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	990.01	2.76	14.73	2.30	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	2391.89	5.27	26.34	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	945.65	5.00	14.99	1.92	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	662.37	3.26	14.67	2.61	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	250.81	0.00	11.37	0.67	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	840.27	1.93	13.10	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	2221.44	4.79	32.18	3.77	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	3553.25	12.42	47.21	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	814.41	3.77	24.06	0.94	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1227.51	3.62	25.35	3.02	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	457.30	2.54	34.08	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	907.76	5.58	21.54	1.99	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	855.97	2.47	23.19	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	1607.76	5.90	62.56	3.54	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	935.26	3.50	18.09	1.75	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	801.84	4.39	35.55	1.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	2170.10	7.63	135.63	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	2250.96	6.57	31.64	2.39	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1224.28	3.40	38.82	3.88	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	286.47	11.41	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	563.85	22.04	7.48	4.99	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	327.22	11.24	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	1521.10	44.40	25.06	10.15	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	450.33	11.70	7.52	6.27	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	426.57	9.40	6.03	3.25	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	554.34	8.10	3.04	2.36	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	444.54	6.37	2.73	2.28	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	508.61	9.62	5.68	4.37	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	405.11	6.66	2.79	1.72	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	500.75	6.67	3.01	3.23	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	608.99	10.71	7.72	5.48	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	428.87	7.21	3.09	0.86	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	476.71	5.13	4.16	1.28	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	335.21	15.11	0.00	3.36	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	325.46	11.69	6.06	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2794.50	5.29	10.58	7.93	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	394.70	8.11	3.53	3.17	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	616.81	18.89	5.81	5.81	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	308.24	3.32	2.80	3.50	0.17
Hepatocyte, donor1	11523-119I2	12449.84	399.50	158.59	140.43	23.00
Hepatocyte, donor2	11603-120I1	5142.13	182.07	71.10	68.95	14.01
Hepatocyte, donor3	11684-122I1	5296.67	188.97	142.95	79.76	7.36
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1346.49	35.25	15.01	18.28	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	1433.38	40.55	22.55	11.89	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	1091.62	11.53	7.68	3.16	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	105.07	9.55	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	220.29	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	538.52	12.46	2.77	6.92	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	132.64	2.50	7.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	213.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	530.52	12.81	7.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	233.11	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	490.55	16.24	8.12	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	330.13	6.67	0.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	519.17	0.00	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	483.07	5.29	2.65	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	124.17	3.33	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	209.53	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	159.36	7.56	3.78	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	102.08	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	146.35	14.63	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	175.72	7.11	4.52	2.58	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	212.51	3.22	1.61	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	191.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	178.46	6.52	1.63	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	42.40	2.10	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	215.59	28.74	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	203.33	2.41	5.63	3.21	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	109.87	4.62	2.77	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	361.94	15.08	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	89.69	3.30	1.42	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	89.79	5.44	5.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	265.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	218.45	2.15	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	190.57	5.08	0.00	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	168.98	4.46	0.64	3.83	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	145.81	0.00	5.47	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	395.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	382.02	12.85	7.85	4.28	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	152.64	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	222.85	3.40	15.12	2.47	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	214.23	5.27	1.76	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	154.01	3.14	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	152.99	2.09	2.78	2.78	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	278.85	4.43	6.64	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	295.02	9.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	369.70	13.08	5.23	5.23	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	389.21	6.75	2.25	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	317.10	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	323.23	6.40	10.67	6.40	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	254.92	9.70	2.77	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	173.83	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	182.24	7.36	6.44	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	214.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	422.19	6.21	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	297.12	10.57	6.34	1.06	3.17
Keratinocyte - epidermal, donor1	11272-116H3	364.34	8.98	3.26	3.43	0.33
Keratinocyte - epidermal, donor2	11349-117G8	231.33	2.34	1.17	2.93	0.00
Keratinocyte - epidermal, donor3	11421-118F8	799.56	10.98	7.10	5.40	0.57
Keratinocyte - oral, donor1	11251-116E9	465.31	9.54	6.13	2.72	0.34
Keratocytes, donor1	11527-119I6	301.54	5.50	2.75	0.34	0.00
Keratocytes, donor2	11607-120I5	460.52	5.86	4.69	1.17	1.17
Keratocytes, donor3	11688-122I5	298.96	4.74	1.58	3.16	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	263.75	37.36	4.40	6.59	4.40
Lens Epithelial Cells, donor1	11529-119I8	685.00	17.26	9.71	7.55	1.08
Lens Epithelial Cells, donor2	11609-120I7	600.88	4.96	3.58	2.42	0.12
Lens Epithelial Cells, donor3	11690-122I7	77.20	1.51	0.71	0.71	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	477.63	7.47	11.74	2.73	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	1385.05	12.84	14.23	6.70	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	2593.52	50.84	38.72	25.03	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	697.95	15.06	12.91	6.45	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3073.81	36.24	60.51	19.86	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1014.64	25.34	31.27	12.51	3.02
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	1391.64	26.27	22.16	9.03	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	893.72	9.35	12.89	5.06	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	2460.88	49.26	47.43	24.21	1.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	765.75	14.63	16.61	6.33	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	1449.86	16.67	16.48	10.28	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	868.72	17.22	21.48	10.37	1.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	1673.48	31.01	23.69	10.10	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	1371.27	15.50	12.16	8.59	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	1579.50	35.71	30.08	14.97	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	1188.72	25.56	31.41	5.24	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1073.33	13.09	19.33	3.74	2.49
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	1493.02	28.36	41.17	13.54	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	1426.70	23.70	23.70	9.87	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	1232.99	19.04	14.64	8.49	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	815.74	18.17	30.62	8.21	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	1419.49	26.19	20.37	11.15	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	947.38	10.50	13.20	8.35	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	1150.47	29.06	32.70	13.78	1.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	770.36	18.66	26.96	5.18	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	1703.18	14.66	12.56	11.73	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	1575.00	39.55	27.22	15.79	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	925.88	24.08	38.52	8.94	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	762.00	10.54	9.60	4.89	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	940.27	22.37	27.46	11.13	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	1478.45	27.62	21.32	8.24	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	932.82	10.92	12.24	5.29	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1671.92	28.62	32.58	14.87	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	1318.32	30.73	22.58	12.59	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	881.84	8.40	11.37	5.68	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	981.57	20.07	14.02	9.76	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	1224.48	24.44	35.06	7.40	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	1248.36	15.83	15.52	4.26	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	1526.89	32.89	26.73	14.00	1.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	1147.04	21.69	36.27	8.53	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1177.04	15.03	11.15	5.33	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	764.19	16.49	30.19	7.00	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	755.24	16.83	21.84	5.73	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	512.88	6.21	4.57	1.96	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	659.66	12.48	19.54	5.89	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	574.46	6.06	15.22	3.71	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	692.82	5.63	9.22	4.10	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	764.39	22.97	15.22	5.97	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	154.09	2.27	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1101.60	35.29	13.04	11.51	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	716.99	14.84	5.94	5.20	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	1911.27	53.31	22.85	18.62	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1595.14	35.17	16.18	15.47	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1425.23	28.02	9.34	8.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	1937.41	86.57	31.95	27.82	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	871.87	22.60	11.89	8.33	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	418.00	7.69	6.79	2.94	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	1603.91	47.40	19.78	15.41	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1510.79	41.87	16.66	12.60	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	480.16	13.14	5.69	3.79	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	1800.93	53.41	16.43	23.62	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	911.07	23.29	5.65	6.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	842.21	10.66	8.66	5.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	2750.68	76.92	25.98	21.39	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1353.77	35.49	12.54	12.54	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1353.60	33.25	14.36	16.82	2.27
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	2050.53	70.56	24.54	23.93	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	1521.58	62.79	24.46	13.05	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1580.77	51.23	27.07	17.08	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1848.60	56.61	22.98	24.10	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1200.35	34.00	13.39	10.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	2341.59	61.83	25.26	22.35	3.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	1153.57	31.09	11.66	9.86	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1002.50	26.00	9.96	10.51	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	2115.97	78.47	32.52	25.45	3.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	1567.31	41.30	20.65	15.86	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	895.69	40.29	8.06	9.21	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	1900.34	44.52	27.63	23.41	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	2236.78	77.56	35.10	31.14	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	762.22	20.51	8.20	6.56	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	1586.11	37.05	24.40	9.49	4.07
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	1547.60	44.52	15.08	20.83	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	796.95	23.15	5.98	7.47	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	1849.05	66.52	34.19	22.67	2.60
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	887.77	22.40	7.75	10.77	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	650.79	23.98	9.42	1.71	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1461.31	47.31	31.65	16.66	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1668.75	62.14	16.89	16.89	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	694.64	15.64	12.80	9.95	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1286.88	42.28	20.97	15.47	3.09
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1563.55	61.19	18.25	26.30	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	850.45	26.26	9.43	7.41	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	2620.64	73.71	50.75	27.41	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	139.55	1.16	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	640.99	27.50	6.35	8.46	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	1563.79	44.42	26.01	12.00	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	1495.18	45.79	9.45	16.72	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1627.32	51.36	23.00	13.80	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	3040.56	128.25	53.27	34.53	3.95
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1535.60	52.69	10.35	13.17	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1289.74	42.74	18.60	14.08	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1731.30	43.26	24.78	13.52	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1860.51	49.91	13.77	29.26	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1451.82	63.68	26.72	19.60	3.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1678.28	38.32	28.54	18.77	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	1183.57	36.95	7.92	13.85	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1081.44	30.62	15.57	11.94	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	2527.38	69.14	27.13	21.88	4.38
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1624.75	43.05	11.18	13.42	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	1583.29	38.86	22.97	20.32	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1918.16	59.01	37.03	17.74	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1621.85	41.52	15.19	20.25	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1394.76	38.45	12.02	12.02	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1770.27	46.12	23.85	11.13	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	1503.86	48.00	15.19	16.41	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	886.07	35.97	5.53	13.14	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1564.04	41.04	27.74	14.44	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1784.22	63.52	17.04	23.24	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	1423.36	53.21	5.44	13.30	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1936.26	63.06	28.52	21.87	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	1228.24	30.92	14.93	12.26	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	1169.45	42.53	4.60	13.22	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	2242.57	79.71	41.14	27.77	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	1337.61	31.83	14.85	10.61	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	863.15	43.13	3.40	13.05	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	1533.47	52.00	15.81	15.81	2.91
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	1515.19	46.98	14.09	20.36	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	976.64	35.07	5.85	13.36	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1371.61	34.85	19.05	11.62	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	1012.94	33.45	4.68	19.40	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	605.22	18.71	3.21	8.55	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	1008.22	44.85	17.38	11.72	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	915.01	21.11	7.34	6.42	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	1647.52	53.35	6.22	16.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	615.46	14.82	10.26	7.41	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	1060.62	30.68	6.14	6.14	4.60
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	1189.56	41.59	3.28	14.23	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1159.94	39.64	18.71	10.25	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	405.53	7.80	6.24	2.86	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	1078.21	25.86	7.96	11.94	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	1575.59	39.49	24.94	27.02	6.24
Macrophage - monocyte derived, donor1	11232-116C8	217.89	7.29	7.07	2.73	0.00
Macrophage - monocyte derived, donor2	11313-117C8	242.60	6.42	3.12	1.47	0.00
Macrophage - monocyte derived, donor3	11389-118C3	421.56	12.32	6.69	4.98	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	104.08	4.25	2.12	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	851.21	16.80	10.30	5.70	0.32
Mallassez-derived cells, donor3	11930-125I4	891.88	9.17	6.53	3.47	0.56
Mammary Epithelial Cell, donor1	11273-116H4	1467.95	24.01	28.80	8.67	0.90
Mammary Epithelial Cell, donor2	11350-117G9	1090.44	9.84	6.37	6.37	0.58
Mammary Epithelial Cell, donor3	11422-118F9	198.54	5.24	1.25	0.75	0.75
Mast cell - stimulated, donor1	11487-119E2	7227.48	113.22	32.54	40.00	9.49
Mast cell, donor1	11563-120D6	1526.84	33.20	12.54	10.38	1.30
Mast cell, donor2	11565-120D8	1563.73	45.47	12.18	15.45	3.27
Mast cell, donor3	11566-120D9	349.17	11.03	11.48	2.25	0.90
Mast cell, donor4	11567-120E1	337.74	15.07	8.51	4.79	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	3106.78	32.71	36.82	12.97	1.22
Mast cell, expanded and stimulated, donor8	11942-126A7	1466.79	0.00	9.34	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	715.64	12.85	8.72	5.74	0.69
Mast cell, expanded, donor8	11941-126A6	1104.12	1.17	22.59	1.17	1.51
Melanocyte - dark, donor1	11502-119F8	341.08	5.37	3.68	2.39	0.30
Melanocyte - dark, donor2	11582-120F7	412.18	13.84	4.85	3.11	1.73
Melanocyte - dark, donor3	11663-122F7	730.42	11.30	6.16	3.04	0.58
Melanocyte - light, donor1	11274-116H5	955.33	30.32	12.69	8.93	1.18
Melanocyte - light, donor2	11351-117H1	676.32	49.82	30.03	5.46	6.82
Melanocyte - light, donor3	11423-118G1	306.13	14.74	4.34	2.60	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	405.88	12.08	5.94	4.06	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	562.36	17.21	6.99	5.65	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	1333.92	24.64	18.48	11.79	2.14
Meningeal Cells, donor1	11493-119E8	294.27	6.33	0.50	1.74	0.12
Meningeal Cells, donor2	11573-120E7	259.69	10.12	0.88	2.64	0.00
Meningeal Cells, donor3	11654-122E7	367.16	4.65	3.83	2.04	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	169.10	3.99	2.85	1.43	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	546.33	15.70	6.44	4.83	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1159.09	23.65	9.20	6.57	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	651.46	10.47	7.85	3.92	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	1094.35	19.38	15.07	5.02	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	678.29	13.34	5.08	4.02	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	892.70	15.58	6.03	3.52	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	583.00	12.31	4.40	1.76	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	835.06	14.61	8.77	5.84	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	428.85	8.80	3.27	3.07	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	395.16	4.71	1.25	1.39	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	893.62	18.59	7.06	4.09	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	2010.32	21.18	21.32	7.50	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	929.09	14.54	7.72	3.86	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	929.55	18.68	7.01	7.01	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	754.39	14.73	5.12	5.76	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	319.71	4.61	5.32	3.90	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	416.55	8.13	10.01	3.13	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	296.81	7.26	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	540.69	17.24	11.40	5.57	1.33
Mesothelial Cells, donor2	12156-128G5	215.70	7.01	1.50	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	1879.75	37.79	13.01	16.33	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	31.06	2.70	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	250.95	16.25	7.88	4.93	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	601.58	17.67	9.13	5.89	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	185.97	9.92	1.55	4.03	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	1218.46	27.38	11.62	10.16	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	387.91	13.76	7.01	4.25	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	594.88	18.15	8.84	11.17	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	392.00	15.44	7.72	7.11	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	891.71	24.95	11.48	10.30	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	653.08	37.17	7.08	13.27	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1607.13	30.02	12.54	16.72	2.66
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	30.27	1.32	0.00	2.63	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	412.14	17.61	7.00	4.24	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	174.04	9.21	2.76	3.68	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	445.00	19.08	7.45	6.86	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	50.30	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	452.38	20.07	6.27	6.27	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1456.19	19.73	11.17	9.03	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	355.96	18.88	10.13	5.76	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	718.10	13.67	8.62	7.57	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	212.80	5.30	1.63	2.45	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	346.48	13.95	7.72	5.15	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	537.28	13.12	8.00	7.56	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	340.35	11.39	5.04	3.29	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	362.98	8.62	8.62	8.62	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	29.83	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	185.91	11.96	5.71	4.08	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	490.53	13.82	7.65	8.82	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	34.89	1.09	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	412.32	11.53	7.69	2.88	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	941.34	24.41	11.61	12.81	2.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	503.08	12.01	13.52	5.01	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	431.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	2.04	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	320.56	11.82	6.57	1.31	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	39.73	4.41	1.10	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	29.46	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	387.50	10.41	8.68	3.97	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	77.24	7.65	0.00	1.39	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	374.35	11.62	9.57	6.15	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	77.02	6.13	2.19	1.31	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.24	2.13	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	326.56	12.06	5.89	2.81	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	80.22	7.48	0.83	1.66	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	30.89	0.58	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	405.74	14.78	8.14	3.92	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	334.33	11.69	7.51	4.59	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	114.52	3.69	3.69	6.46	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	213.99	9.11	1.14	5.69	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	88.85	5.11	2.63	1.80	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	236.34	4.15	8.03	1.30	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	140.70	5.58	2.57	2.14	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.07	0.64	0.64	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	159.33	6.67	5.87	1.33	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	316.09	10.78	1.20	3.59	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	100.29	4.38	2.26	1.98	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	237.29	7.01	4.78	1.59	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	178.45	5.53	1.55	2.43	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	23.51	0.00	2.28	1.14	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	201.15	8.81	5.68	3.98	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	533.89	11.06	3.69	4.67	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	0.65	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	99.38	4.41	1.18	2.06	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	267.28	6.92	1.15	2.88	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	162.38	3.30	2.89	1.65	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	94.40	2.98	2.38	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	1446.48	52.74	45.20	11.30	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	295.85	10.69	7.13	1.78	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1451.30	31.87	18.73	12.16	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1099.29	30.51	17.88	8.42	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	491.25	12.45	10.48	3.36	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	230.04	6.52	4.66	3.73	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1345.52	26.66	10.89	9.76	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	261.55	10.92	6.92	1.86	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	267.71	4.64	2.71	2.15	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	797.14	25.05	14.73	7.37	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	883.08	26.02	16.49	10.63	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4687.01	136.89	76.22	52.89	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	467.10	5.34	2.67	4.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	776.64	30.91	7.73	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2113.80	42.42	33.33	17.17	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1345.87	42.16	20.24	10.12	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	766.77	17.71	4.09	6.81	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	448.87	6.99	3.81	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	667.31	5.67	4.86	4.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1815.54	74.01	28.70	10.57	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	177.02	28.55	102.78	11.42	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	1543.14	123.97	146.81	45.67	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	679.60	76.04	42.77	52.28	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	1970.20	150.59	50.20	12.55	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	829.43	15.51	6.46	4.96	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	1364.54	16.20	6.79	8.88	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	332.41	19.36	20.02	4.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	241.66	18.78	16.28	5.01	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	693.26	15.78	20.92	4.18	1.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	266.51	23.94	17.55	9.58	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	221.66	10.88	30.60	6.12	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	6839.70	51.45	73.51	36.75	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	260.33	11.30	15.07	3.35	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	312.40	15.34	15.81	3.25	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	187.27	6.76	23.24	3.78	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	510.88	10.51	5.89	5.26	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11947.56	167.02	579.01	89.08	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	522.17	15.39	15.88	4.47	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	709.16	14.07	25.71	7.04	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	354.98	16.77	21.53	2.95	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	259.98	6.04	28.58	1.63	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	429.57	10.75	10.39	6.01	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	543.70	28.11	52.51	5.30	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	204.10	13.21	18.01	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	2114.77	45.94	71.21	16.74	3.94
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	278.25	15.45	16.91	3.09	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	787.90	19.75	13.58	13.23	2.82
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	267.93	22.50	66.10	2.81	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	427.07	19.77	43.21	7.82	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	220.12	9.32	20.24	2.89	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	2797.73	56.91	101.40	25.52	7.24
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	6022.76	65.74	222.50	42.98	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	403.69	9.58	8.24	5.12	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	731.20	31.75	104.15	8.47	3.81
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	521.46	30.86	38.21	5.93	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	183.72	8.58	18.46	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27065.22	397.22	279.86	153.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	235.92	11.66	6.00	3.67	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	324.17	10.37	7.21	4.51	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	529.33	19.05	30.95	6.35	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	357.53	13.00	38.07	4.64	4.64
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	285.67	17.41	20.05	3.78	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	452.00	26.72	26.07	2.61	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	170.83	4.79	5.67	1.74	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	614.66	14.47	8.59	9.50	4.07
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	354.53	18.52	67.03	4.41	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	399.57	23.27	69.81	5.32	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	239.09	12.40	6.45	2.48	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	301.67	22.59	20.67	5.74	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	614.87	21.17	28.43	5.75	2.12
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	935.81	15.69	15.47	7.74	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	449.96	22.36	21.01	4.07	2.71
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	8640.22	97.08	229.93	35.77	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	156.08	7.32	10.36	4.88	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	322.60	18.88	19.51	4.72	2.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	228.50	9.68	51.75	3.33	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	398.73	16.61	51.42	8.70	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	5823.53	122.43	425.12	66.88	12.47
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	8709.68	91.04	536.14	35.41	5.06
Myoblast, donor1	11241-116D8	586.23	16.15	12.67	5.71	0.75
Myoblast, donor2	11322-117D8	912.53	26.85	16.49	11.89	0.38
Myoblast, donor3	11398-118D3	373.15	7.74	6.05	2.52	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	2230.58	40.28	38.53	16.05	0.29
Natural Killer Cells, donor1	11230-116C6	724.51	17.84	11.38	10.76	0.62
Natural Killer Cells, donor2	11311-117C6	1309.66	29.25	12.06	10.86	1.21
Natural Killer Cells, donor3	11387-118C1	1895.39	36.26	18.04	14.72	0.92
Neural stem cells, donor1	11275-116H6	2216.11	38.83	72.59	13.79	2.54
Neural stem cells, donor2	11352-117H2	837.65	26.96	171.38	7.70	5.78
Neurons, donor1	11494-119E9	1332.48	38.69	35.27	14.79	1.14
Neurons, donor2	11574-120E8	548.87	0.88	9.25	0.44	0.66
Neurons, donor3	11655-122E8	1516.07	33.71	110.17	9.04	2.47
Neutrophils, donor1	11233-116C9	184.67	15.78	9.28	5.57	3.71
Neutrophils, donor2	11314-117C9	675.44	37.69	20.29	23.19	2.90
Neutrophils, donor3	11390-118C4	104.45	7.33	5.50	3.67	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	193.66	4.63	2.85	1.66	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	397.89	6.51	4.88	1.63	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	131.96	4.21	0.20	1.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	800.31	12.94	9.09	3.30	0.96
Olfactory epithelial cells, donor2	11934-125I8	992.08	19.54	16.50	8.97	1.16
Olfactory epithelial cells, donor3	11935-125I9	783.30	13.96	10.90	5.68	0.57
Olfactory epithelial cells, donor4	11936-126A1	725.32	17.63	15.00	6.62	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	922.59	14.44	7.22	3.01	0.00
Osteoblast - differentiated, donor1	11276-116H7	152.71	4.68	1.28	3.83	0.43
Osteoblast - differentiated, donor2	11353-117H3	21.72	4.57	3.43	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	177.52	1.86	1.86	3.72	0.00
Osteoblast, donor1	11277-116H8	223.97	5.28	49.25	1.76	1.37
Osteoblast, donor2	11354-117H4	1505.07	28.09	9.83	4.21	0.00
Osteoblast, donor3	11426-118G4	299.12	8.18	1.78	3.73	0.71
Pancreatic stromal cells, donor1	11249-116E7	567.66	11.37	6.23	4.80	0.34
Pericytes, donor1	11491-119E6	337.92	7.34	0.45	2.45	0.22
Pericytes, donor2	11571-120E5	329.81	14.94	1.13	4.75	0.68
Pericytes, donor3	11652-122E5	597.94	15.67	7.12	4.68	0.41
Perineurial Cells, donor1	11499-119F5	436.04	6.67	3.62	2.26	0.00
Perineurial Cells, donor2	11579-120F4	163.87	1.47	0.92	0.64	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	796.21	13.39	10.52	8.61	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	612.65	17.14	10.77	6.61	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	778.82	15.66	11.52	7.64	1.04
Placental Epithelial Cells, donor1	11278-116H9	25.11	0.48	0.96	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	185.18	0.00	2.22	4.44	0.00
Placental Epithelial Cells, donor3	11427-118G5	98.36	1.37	0.98	1.18	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	925.94	54.43	24.05	13.92	2.53
Preadipocyte - breast, donor1	11467-119B9	354.73	9.57	5.44	3.94	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	23.76	0.78	0.39	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	683.55	22.06	9.91	6.98	0.45
Preadipocyte - omental, donor1	11468-119C1	471.20	8.95	6.50	5.65	0.32
Preadipocyte - omental, donor2	11329-117E6	676.53	11.35	5.24	5.24	0.00
Preadipocyte - omental, donor3	11403-118D8	1095.57	26.64	18.62	11.46	2.15
Preadipocyte - perirenal, donor1	11469-119C2	266.74	10.83	1.97	5.91	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	162.16	7.68	1.23	3.99	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	2936.83	82.87	34.35	29.57	3.36
Preadipocyte - subcutaneous, donor3	11428-118G6	702.59	15.84	4.60	5.79	0.00
Preadipocyte - visceral, donor1	11280-116I2	1391.43	22.82	12.57	8.38	0.65
Preadipocyte - visceral, donor2	11357-117H7	1725.22	32.21	13.35	13.35	2.30
Preadipocyte - visceral, donor3	11429-118G7	469.06	19.64	1.99	8.05	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	649.27	15.99	8.75	6.79	0.30
Prostate Epithelial Cells, donor2	11331-117E8	699.95	22.48	8.12	9.07	1.08
Prostate Epithelial Cells, donor3	11404-118D9	1780.84	35.33	14.33	12.86	1.41
Prostate Stromal Cells, donor1	11254-116F3	522.35	12.42	9.91	5.47	0.23
Prostate Stromal Cells, donor2	11332-117E9	1855.56	30.30	12.37	18.29	1.43
Prostate Stromal Cells, donor3	11405-118E1	679.04	16.16	7.61	5.84	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	430.31	7.30	1.09	4.38	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	343.44	4.16	4.23	1.94	0.21
Renal Epithelial Cells, donor1	11517-119H5	532.09	8.62	4.57	3.55	0.00
Renal Epithelial Cells, donor2	11597-120H4	1120.33	15.65	9.96	8.54	0.71
Renal Epithelial Cells, donor3	11678-122H4	797.59	6.67	5.29	2.65	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	379.92	10.89	1.36	5.45	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	486.50	12.53	1.08	5.79	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	1108.28	20.20	8.66	6.88	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	787.88	17.97	5.32	6.65	0.67
Renal Mesangial Cells, donor1	11518-119H6	483.53	0.88	7.04	0.44	0.44
Renal Mesangial Cells, donor2	11598-120H5	968.06	23.83	11.91	6.27	1.25
Renal Mesangial Cells, donor3	11679-122H5	458.84	0.28	6.66	1.66	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	722.86	13.15	5.64	4.03	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	724.05	16.02	5.90	5.48	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	815.16	11.76	7.33	4.24	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	343.03	6.22	5.44	1.04	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	954.49	16.20	10.23	5.12	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	890.19	10.29	5.15	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	313.38	3.51	0.50	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	1748.62	24.32	27.13	12.43	2.54
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	2767.77	132.22	90.23	33.06	5.36
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14199.01	307.66	89.71	95.76	12.11
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	7721.69	250.00	65.55	90.49	19.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	429.86	9.62	0.65	4.03	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	1135.46	23.73	12.02	12.12	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	969.72	10.71	8.03	5.47	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	2068.67	37.71	6.82	22.33	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	1405.30	25.99	10.49	12.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	2900.01	69.80	35.36	28.89	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	1214.38	29.71	3.42	8.76	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	849.85	26.93	9.23	13.31	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	292.08	5.38	3.58	2.15	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	1678.58	39.74	3.30	13.34	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	1027.86	20.28	10.19	9.01	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	1736.97	33.85	21.91	12.83	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	993.16	30.97	1.34	7.84	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	643.57	14.81	7.45	7.17	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	4474.07	34.76	15.78	20.86	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	543.30	21.10	1.86	7.70	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	1061.99	23.75	10.03	8.76	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	5282.30	82.49	67.79	40.10	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	753.64	19.97	2.03	9.18	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	1482.82	42.61	18.22	13.73	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	1148.61	22.73	12.99	11.79	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	524.56	15.32	1.28	6.93	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	1549.21	25.38	14.72	14.72	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	1345.62	27.80	16.66	13.03	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	1744.51	47.88	2.83	11.56	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	1291.87	27.58	11.31	9.33	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	1270.25	24.09	14.03	9.59	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	1228.99	29.65	2.49	12.03	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	784.41	17.92	8.41	10.40	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	1120.87	20.05	16.92	12.12	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	1443.29	30.95	2.29	11.17	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	313.17	7.83	4.60	3.75	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	2178.58	34.12	19.86	21.98	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1738.46	40.06	1.89	11.35	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	430.44	10.97	4.80	6.04	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	1216.82	23.80	12.81	13.30	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	948.79	22.84	1.70	9.71	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	1909.39	35.21	32.85	14.65	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	902.01	14.13	9.33	8.26	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	823.51	25.30	0.97	7.74	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	1566.71	33.57	35.24	19.29	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	1805.81	34.46	28.42	14.31	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	1267.87	39.84	2.64	13.94	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	6588.98	151.97	108.65	66.73	6.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	2065.33	51.98	47.75	19.95	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	1584.54	47.73	3.92	17.01	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	1376.93	18.92	17.47	9.75	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	913.86	20.69	61.45	10.34	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	1166.11	38.58	2.41	10.85	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	6762.13	200.63	78.26	84.59	11.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	3580.70	81.18	39.54	30.55	4.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	1694.25	46.40	6.61	17.36	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	609.39	69.16	20.70	25.61	6.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	2240.44	139.43	63.70	37.26	7.21
Schwann Cells, donor1	11498-119F4	422.60	13.73	2.82	5.27	0.56
Schwann Cells, donor2	11578-120F3	540.98	10.21	13.61	3.40	0.00
Schwann Cells, donor3	11659-122F3	731.07	11.17	5.04	5.04	0.22
Sebocyte, donor1	11220-116B5	619.53	21.91	3.83	3.83	0.00
Sebocyte, donor2	11301-117B5	1144.75	29.87	12.87	10.11	5.06
Sebocyte, donor3	11378-118B1	413.26	22.88	11.54	5.36	0.82
Sertoli Cells, donor1	11255-116F4	488.70	18.22	6.63	13.25	0.00
Sertoli Cells, donor2	11333-117F1	1677.67	36.72	2.82	14.12	2.82
Skeletal Muscle Cells, donor1	11281-116I3	238.07	5.81	2.20	1.32	0.09
Skeletal Muscle Cells, donor2	11358-117H8	145.29	5.78	1.45	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	181.42	5.02	0.84	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	457.14	16.81	3.30	6.13	0.47
Skeletal Muscle Cells, donor5	11455-119A6	607.96	17.09	4.16	7.88	0.45
Skeletal Muscle Cells, donor6	11459-119B1	466.48	14.77	2.46	6.00	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	726.30	16.76	11.97	6.05	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	1267.22	29.54	16.98	12.98	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	643.48	15.68	8.23	7.34	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	412.33	7.08	2.95	2.19	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	191.80	0.72	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	87.10	3.44	0.28	0.83	0.14
Skin - palm, donor1	10286-104F7	1181.89	102.07	24.17	42.98	13.43
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	478.89	19.32	8.51	4.47	1.73
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	823.62	32.72	2.45	4.09	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	100.10	5.71	3.51	1.56	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	487.36	14.32	11.82	5.98	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	522.54	19.41	9.28	5.34	1.69
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1351.14	47.15	21.14	9.73	3.17
Small Airway Epithelial Cells, donor3	11406-118E2	755.88	23.61	14.62	8.09	1.20
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	47.52	1.85	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3774.07	98.71	5.11	28.68	1.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	320.37	8.82	5.29	2.94	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	246.85	6.19	3.31	1.33	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	109.86	5.51	1.58	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	225.59	5.41	6.18	4.64	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	905.68	14.01	7.01	11.01	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	35.27	1.73	0.40	0.67	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	2863.11	70.93	46.99	28.15	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.25	2.05	0.00	0.77	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	249.08	9.44	9.12	3.26	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	366.50	7.97	2.36	5.02	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	389.51	9.25	6.41	4.84	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	382.29	5.69	2.60	3.42	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	273.38	9.44	4.57	3.35	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	78.29	2.53	2.27	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	238.71	6.12	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	53.88	4.77	0.48	1.91	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	378.27	9.88	6.78	5.16	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	594.27	19.16	6.24	7.10	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	436.73	9.55	6.72	4.62	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	67.44	2.94	1.39	0.77	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	527.08	15.09	4.31	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	90.55	4.78	0.00	1.20	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	936.12	7.85	2.39	4.44	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	1116.92	6.60	6.20	4.24	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	2008.90	34.72	20.33	10.77	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	709.96	12.97	5.46	4.78	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	155.78	7.85	0.00	1.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	2040.19	25.96	20.66	7.95	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	501.88	15.05	2.13	3.73	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	1781.12	45.71	14.65	16.03	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	269.39	7.36	2.79	4.82	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	265.06	6.03	4.98	1.36	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	519.12	9.00	6.00	2.25	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	196.42	11.63	3.88	6.46	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	260.44	6.98	5.58	2.79	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	341.81	9.09	3.03	3.03	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	110.63	5.64	0.00	2.82	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	654.90	11.21	1.47	2.36	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	100.13	1.42	0.33	0.58	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	263.01	4.20	2.34	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	162.34	4.89	2.16	2.16	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	447.70	9.69	5.10	4.33	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	179.20	10.34	1.13	1.32	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	364.03	5.31	1.82	2.38	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	159.70	2.77	1.17	0.84	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	548.09	9.52	3.33	4.76	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	204.29	6.36	2.45	2.94	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	745.26	19.66	1.55	6.41	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	328.86	9.95	6.44	2.34	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	1333.51	35.57	17.88	8.94	1.36
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	2257.11	51.30	41.78	20.36	3.44
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2554.90	80.34	44.26	27.90	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	3128.75	111.39	47.43	21.20	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1400.48	48.83	26.40	10.79	5.11
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	2013.06	41.75	18.51	12.60	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	2559.83	112.25	58.41	29.20	4.06
Smooth muscle cells - airway, control, donor2	11967-126D5	3858.22	96.64	57.50	27.55	2.80
Smooth muscle cells - airway, control, donor3	11968-126D6	1720.93	54.34	30.93	8.78	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	1017.56	34.38	17.42	9.17	1.38
Synoviocyte, donor1	11291-117A4	1059.92	16.16	18.18	7.07	0.67
Synoviocyte, donor2	11368-117I9	1356.92	30.84	25.65	15.25	1.01
Synoviocyte, donor3	11440-118H9	2323.68	79.31	19.44	33.29	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	444.16	11.08	2.50	2.50	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	473.71	3.96	1.98	5.95	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	233.63	3.94	2.55	1.85	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	187.67	5.59	8.32	1.00	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	279.87	8.50	3.09	3.09	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	130.57	4.58	1.15	4.01	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	1711.51	28.42	29.03	9.96	2.95
Urethra, donor2	10319-105A4	5632.67	210.42	170.85	77.33	26.98
Urothelial Cells, donor1	11520-119H8	613.15	21.25	5.84	4.52	0.53
Urothelial Cells, donor2	11600-120H7	622.88	21.63	13.22	6.41	1.20
Urothelial Cells, donor3	11681-122H7	516.63	16.27	7.33	3.90	0.23
Urothelial cells, donor0	11216-116B1	390.07	13.37	7.13	2.67	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	209.99	6.23	0.89	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	214.44	10.01	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	476.43	21.90	9.58	12.32	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	171.48	6.89	3.44	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	191.74	4.65	4.07	4.07	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	223.87	4.16	0.00	4.16	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	300.12	9.18	0.92	10.10	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	341.42	16.43	5.48	8.22	0.91
Wilms' tumor cell line:G-401	10809-111A8	1110.62	20.48	16.28	6.04	0.86
Wilms' tumor cell line:HFWT	10597-108E3	609.87	28.16	18.48	19.36	4.40
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1664.73	34.08	22.90	13.41	1.40
achilles tendon, donor2	10292-104G4	1636.69	88.86	47.53	35.13	14.47
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	4360.77	90.25	63.99	35.44	4.08
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1757.79	20.20	25.54	6.97	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	460.23	12.11	8.19	5.10	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2122.76	54.15	39.73	14.97	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	6312.86	65.77	28.95	27.55	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	400.76	10.36	4.65	3.38	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	4470.53	71.59	26.40	27.49	3.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1654.16	45.83	23.79	10.13	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	6658.30	8.17	37.57	10.62	4.08
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	2635.38	96.69	57.47	25.63	5.44
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3386.52	43.24	14.54	16.19	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	14556.73	218.43	85.81	105.31	11.70
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	3685.81	40.43	34.62	17.43	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	5559.91	65.50	36.76	27.18	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	8160.33	112.22	52.90	41.79	3.21
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1207.45	2.32	18.13	3.25	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	1696.01	44.42	9.05	11.52	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	133.83	0.92	2.15	0.31	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1495.19	2.99	19.63	2.99	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	826.78	1.82	19.11	2.12	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1075.23	2.65	19.02	3.37	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2462.37	34.08	22.72	13.81	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1512.64	4.34	28.35	5.67	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1592.48	105.92	35.31	26.01	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	2320.23	53.11	24.48	13.94	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	1537.37	31.84	20.06	7.85	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	657.94	35.61	7.50	11.25	1.87
adenocarcinoma cell line:IM95m	10796-110I4	855.81	18.13	14.60	8.01	0.47
adipose tissue, adult, pool1	10010-101C1	1648.14	58.64	20.17	24.20	3.10
adipose, donor1	10184-103D4	3561.26	72.71	52.78	35.77	5.86
adipose, donor2	10185-103D5	472.02	18.65	4.87	3.24	2.43
adipose, donor3	10186-103D6	1476.62	29.41	14.16	11.98	2.45
adipose, donor4	10187-103D7	3812.84	61.54	28.60	20.80	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	743.33	13.73	12.15	4.73	0.79
adrenal gland, adult, pool1	10081-102A9	1280.46	29.10	18.19	21.83	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	1376.08	17.48	14.14	10.54	1.73
alveolar cell carcinoma cell line:SW 1573	10708-109H6	1348.45	37.52	32.16	17.86	1.79
amniotic membrane cells, donor1	12235-129G3	571.51	24.58	11.59	5.80	0.93
amniotic membrane cells, donor2	12236-129G4	410.46	13.52	11.16	5.75	0.34
amniotic membrane cells, donor3	12237-129G5	1150.42	38.00	6.78	16.20	1.47
amygdala - adult, donor10196	10167-103B5	9250.41	81.82	158.90	26.09	5.93
amygdala, adult, donor10252	10151-102I7	7931.86	156.33	394.18	89.22	10.75
amygdala, newborn, donor10223	10360-105E9	2252.60	6.13	109.10	6.78	5.81
anaplastic carcinoma cell line:8305C	10428-106D5	652.31	14.01	8.40	5.73	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	2010.54	36.84	18.97	15.66	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	6163.65	89.52	37.75	36.08	7.01
aorta, adult, pool1	10052-101G7	1805.99	36.68	18.04	10.20	2.16
appendix, adult	10189-103D9	332.62	11.26	6.60	3.88	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	2965.41	70.51	35.08	28.55	4.13
artery, adult	10190-103E1	2694.28	81.52	43.48	43.48	8.15
astrocytoma cell line:TM-31	10425-106D2	538.33	13.18	9.56	4.20	0.72
b cell line:RPMI1788	10427-106D4	1119.87	25.43	14.87	8.77	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	488.58	9.99	9.71	4.72	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	655.82	7.44	7.54	2.98	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	484.56	11.38	12.72	5.86	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1001.04	25.72	15.10	16.78	0.00
bladder, adult, pool1	10011-101C2	563.52	22.38	12.39	9.23	1.63
blood, adult, pool1	10053-101G8	575.80	31.00	8.86	13.29	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	301.43	17.98	8.56	8.56	2.57
bone marrow, adult	10192-103E3	15785.53	419.74	261.83	166.68	16.20
brain, adult, donor1	10084-102B3	3936.26	106.61	47.15	35.88	4.10
brain, adult, pool1	10012-101C3	1561.58	60.69	34.63	27.73	3.01
brain, fetal, pool1	10085-102B4	1528.04	24.04	18.70	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	1349.54	61.78	27.09	34.03	5.29
breast carcinoma cell line:MDA-MB-453	10419-106C5	1558.91	32.08	17.35	14.98	2.12
breast, adult, donor1	10080-102A8	643.35	24.62	15.15	5.05	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1790.34	36.46	29.98	13.47	1.52
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	1729.47	51.02	40.51	17.32	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	4402.02	52.26	29.93	23.94	2.07
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	2831.44	71.66	49.39	29.29	2.42
carcinoid cell line:NCI-H1770	10703-109H1	2220.60	60.18	42.79	24.45	3.29
carcinoid cell line:NCI-H727	10735-110B6	1104.09	26.91	13.13	10.72	2.08
carcinoid cell line:SK-PN-DW	10719-109I8	1840.53	57.36	27.57	20.60	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	3070.10	61.75	39.93	21.83	1.60
caudate nucleus - adult, donor10196	10177-103C6	5652.99	69.08	161.19	19.57	4.61
caudate nucleus, adult, donor10252	10164-103B2	7105.51	141.73	475.21	98.89	11.71
caudate nucleus, adult, donor10258	10379-105H1	10460.30	170.40	258.28	71.06	7.64
caudate nucleus, newborn, donor10223	10354-105E3	2290.79	9.89	117.93	7.69	8.42
cerebellum - adult, donor10196	10173-103C2	7335.62	61.18	107.79	17.48	0.00
cerebellum, adult, donor10252	10166-103B4	6658.97	118.71	657.40	79.64	8.54
cerebellum, adult, pool1	10083-102B2	3708.50	61.40	24.49	29.32	0.34
cerebellum, newborn, donor10223	10357-105E6	3305.37	4.15	311.36	9.13	6.64
cerebral meninges, adult	10188-103D8	1165.89	58.75	22.19	26.22	3.78
cerebrospinal fluid, donor2	10294-104G6	3796.21	195.15	103.79	66.51	13.89
cervical cancer cell line:D98-AH2	10552-107I3	1465.57	24.16	22.29	9.49	0.58
cervical cancer cell line:ME-180	10553-107I4	896.19	14.42	18.39	5.30	0.50
cervix, adult, pool1	10013-101C4	688.84	23.31	14.17	10.50	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	783.50	16.86	11.43	7.52	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	245.58	14.37	9.14	7.84	3.92
choriocarcinoma cell line:BeWo	10423-106C9	1443.09	36.16	19.76	16.53	1.24
choriocarcinoma cell line:SCH	10785-110H2	1752.82	30.56	25.01	11.09	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	985.00	45.78	25.62	18.97	3.32
chorionic membrane cells, donor1	12238-129G6	406.86	11.97	5.13	3.99	0.28
chorionic membrane cells, donor2	12239-129G7	510.28	18.69	6.46	5.87	0.89
chorionic membrane cells, donor3	12240-129G8	1617.13	80.77	15.39	29.12	4.40
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1778.26	35.34	11.11	10.10	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	771.28	20.75	7.68	7.68	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	1124.14	2.96	28.72	3.38	2.96
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1310.97	29.79	6.93	7.45	2.57
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1496.98	27.82	9.68	9.92	2.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1493.89	26.88	10.79	6.92	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	1845.65	45.05	28.56	13.25	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	1322.67	16.16	11.21	8.60	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	2840.58	64.92	29.72	25.83	3.20
clear cell carcinoma cell line:TEN	10636-108I6	1505.86	36.09	15.96	10.76	1.56
colon carcinoma cell line:CACO-2	10513-107D9	942.67	16.84	9.88	7.32	1.10
colon carcinoma cell line:COLO-320	10420-106C6	1656.77	28.51	13.68	10.26	1.14
colon, adult, donor1	10082-102B1	2764.44	59.50	28.56	20.23	4.76
colon, adult, pool1	10014-101C5	628.88	37.48	16.80	14.81	3.17
colon, fetal, donor1	10070-101I7	815.75	50.06	13.60	12.98	2.47
common myeloid progenitor CMP, donor1	12130-128D6	22.92	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	300.44	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	2379.62	50.99	30.60	20.82	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1189.49	24.90	12.53	6.94	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	1382.76	29.05	14.52	9.02	1.27
corpus callosum, adult, pool1	10042-101F6	2091.18	35.16	19.13	17.69	1.66
cruciate ligament, donor2	10295-104G7	3126.79	87.53	72.94	36.47	8.10
diaphragm, fetal, donor1	10069-101I6	2412.50	73.84	68.22	25.68	7.22
diencephalon, adult	10193-103E4	2093.90	69.36	18.00	27.60	3.60
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9295.35	129.04	73.71	56.71	4.59
ductal cell carcinoma cell line:KLM-1	10438-106E6	1061.66	28.46	16.16	11.28	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	1190.37	24.55	32.50	9.39	2.41
ductus deferens, adult	10196-103E7	2077.58	49.34	28.41	24.42	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	2501.68	60.49	25.92	25.92	5.76
duodenum, fetal, donor1, tech_rep2	10071-101I8	4290.30	73.56	28.69	30.90	1.47
dura mater, adult, donor1	10041-101F5	834.46	20.23	7.76	6.11	1.57
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	262.27	17.32	9.10	4.00	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	837.26	20.63	13.04	5.73	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	675.19	42.55	9.25	14.80	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	989.26	31.78	16.04	8.48	1.82
embryonic pancreas cell line:1C3IKEI	10606-108F3	544.33	23.77	9.57	10.19	2.47
embryonic pancreas cell line:2C6	10603-108E9	271.89	19.70	3.94	11.82	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	1940.78	67.37	49.27	28.16	4.36
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	2379.98	63.61	46.03	25.19	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	2068.70	49.37	19.30	14.96	1.45
epidermoid carcinoma cell line:A431	10426-106D3	715.53	16.23	9.23	8.23	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	752.96	13.64	7.81	6.38	0.66
epididymis, adult	10197-103E8	750.38	36.00	16.95	16.54	3.14
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1214.73	36.01	24.31	12.60	1.77
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1336.63	35.39	12.58	8.65	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	2668.96	63.30	43.51	26.21	4.72
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	2291.42	57.97	28.44	23.03	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	2363.71	43.58	29.35	18.48	2.91
esophagus, adult, pool1	10015-101C6	521.33	20.70	9.45	7.22	1.59
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	931.00	2.00	13.65	1.75	1.50
eye - muscle inferior rectus, donor1	10272-104E2	56824.56	1697.44	765.42	683.32	188.34
eye - muscle lateral, donor2	10298-104H1	15257.58	481.86	176.75	235.67	35.77
eye - muscle medial, donor2	10299-104H2	10399.65	447.95	226.21	233.65	41.67
eye - muscle superior, donor2	10297-104G9	14660.25	496.43	223.57	245.35	42.42
eye - vitreous humor, donor1	10268-104D7	918.16	45.18	16.03	16.03	5.83
eye, fetal, donor1	10054-101G9	1184.22	32.03	15.00	10.93	2.29
fibrosarcoma cell line:HT-1080	10758-110E2	1035.80	22.82	25.39	11.16	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	1030.40	28.97	45.82	7.12	1.90
frontal lobe, adult, pool1	10040-101F4	2577.44	44.00	20.55	18.86	3.57
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	5629.37	95.48	76.86	44.74	5.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	889.13	22.04	6.58	9.24	0.82
gall bladder, adult	10198-103E9	670.46	31.87	11.35	14.49	1.93
gamma delta positive T cells, donor1	11937-126A2	684.49	23.08	10.74	2.68	0.00
gamma delta positive T cells, donor2	11938-126A3	872.85	17.55	11.95	3.73	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	2798.20	57.87	24.71	23.23	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	1193.18	35.20	19.73	13.93	1.74
gastric cancer cell line:AZ521	10549-107H9	1199.00	21.81	16.72	7.71	0.66
gastric cancer cell line:GSS	10560-108A2	2166.34	40.27	11.90	7.32	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	3681.58	77.45	55.97	36.10	1.37
giant cell carcinoma cell line:LU65	10487-107B1	655.74	11.82	9.52	6.65	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	457.39	10.36	6.02	4.06	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	1347.11	101.51	122.21	30.93	7.23
glioblastoma cell line:A172, tech_rep1	10444-106F3	920.42	35.57	14.04	13.30	2.01
glioblastoma cell line:A172, tech_rep2	10444-106F3	966.78	34.41	16.57	16.57	1.54
glioblastoma cell line:T98G	10485-107A8	1146.89	29.80	19.54	9.16	1.10
glioma cell line:GI-1	10413-106B8	698.51	11.13	6.15	5.86	0.88
globus pallidus - adult, donor10196	10175-103C4	4624.22	64.87	131.93	16.76	2.92
globus pallidus, adult, donor10252	10161-103A8	9504.80	159.39	940.50	108.13	12.94
globus pallidus, adult, donor10258	10367-105F7	7147.27	123.23	219.07	45.18	9.58
globus pallidus, newborn, donor10223	10364-105F4	1483.64	3.73	62.88	7.46	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	7.34	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	513.63	10.93	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	371.09	10.45	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	854.07	1.92	16.32	2.56	3.52
hIPS +CCl2, biol_rep1	14383-156B9	2300.16	43.16	10.56	8.26	0.46
hIPS +CCl2, biol_rep2	14384-156C1	3092.46	48.47	10.06	6.40	3.66
hIPS +CCl2, biol_rep3	14385-156C2	2727.09	39.29	8.37	7.09	0.64
hIPS, biol_rep1	14380-156B6	1963.34	12.94	4.31	1.44	0.00
hIPS, biol_rep2	14381-156B7	2049.37	32.24	2.74	0.69	0.00
hIPS, biol_rep3	14382-156B8	8764.84	136.83	48.55	30.90	4.41
hairy cell leukemia cell line:Mo	10712-109I1	3962.18	81.03	49.42	31.32	1.15
heart - mitral valve, adult	10205-103F7	6022.70	152.17	127.06	80.12	8.67
heart - pulmonic valve, adult	10206-103F8	26176.56	593.55	314.82	309.06	28.50
heart - tricuspid valve, adult	10207-103F9	12309.77	470.44	397.17	240.63	40.80
heart, adult, diseased post-infarction, donor1	10050-101G5	4375.99	77.34	49.99	36.93	5.31
heart, adult, diseased, donor1	10051-101G6	9767.74	149.04	59.62	66.00	5.11
heart, adult, pool1	10016-101C7	618.87	60.02	37.03	22.77	10.35
heart, fetal, pool1	10046-101G1	3025.16	58.63	26.70	23.72	3.80
hepatic mesenchymal tumor cell line:LI90	10778-110G4	470.81	14.81	6.79	7.40	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	248.54	27.35	29.73	11.89	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	3827.25	76.57	50.50	31.93	4.86
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	3285.60	76.10	51.71	32.16	3.40
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	3453.29	84.48	51.03	31.23	4.65
hepatoma cell line:Li-7	10484-107A7	691.98	16.13	14.12	5.34	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1135.75	15.18	9.85	6.53	0.80
hippocampus - adult, donor10196	10169-103B7	8096.78	101.26	142.90	35.96	1.89
hippocampus, adult, donor10252	10153-102I9	11012.62	208.79	668.02	125.93	14.29
hippocampus, adult, donor10258	10374-105G5	13002.48	122.99	25.40	8.47	1.49
hippocampus, newborn, donor10223	10363-105F3	1298.88	6.34	95.52	4.93	3.17
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	4251.04	122.68	81.18	37.23	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1879.31	40.65	27.10	16.89	2.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1979.11	60.17	36.05	18.79	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	734.15	31.01	36.65	10.71	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	854.42	32.79	27.63	12.91	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	627.87	23.16	20.12	12.15	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	477.05	22.77	11.97	6.42	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	573.04	20.47	10.99	7.97	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	377.87	15.01	10.43	7.09	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	483.53	11.60	5.92	2.13	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	848.10	26.04	15.27	8.04	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	365.60	9.43	5.39	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1794.88	41.47	30.83	17.53	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	2150.39	57.48	27.51	24.07	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	5114.33	144.88	81.17	40.15	8.73
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	805.83	28.06	15.46	10.31	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	980.29	27.91	11.34	9.59	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1348.86	60.47	36.98	18.49	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	334.40	13.38	7.72	3.96	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	332.40	14.55	4.55	3.64	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	415.98	21.30	11.28	4.70	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	745.64	21.23	11.43	6.21	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	617.49	19.45	9.00	5.52	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	745.22	23.91	15.54	7.77	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1733.46	40.09	20.51	15.15	2.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1341.41	31.95	18.54	7.99	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2521.73	59.21	40.83	23.68	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	764.37	28.87	8.10	8.80	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	766.51	19.95	7.60	4.75	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	768.35	27.24	17.85	10.59	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	272.52	8.79	5.69	2.07	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	282.93	7.97	3.98	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	275.77	9.24	9.24	2.57	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	458.63	17.64	5.37	4.09	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	405.11	15.90	8.33	3.79	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	579.70	13.78	15.46	4.03	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1488.64	35.50	14.97	12.56	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	2591.95	54.82	45.90	19.16	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1666.36	43.90	30.24	13.66	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	856.34	21.70	6.42	7.64	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	8367.34	126.88	94.34	104.10	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1168.56	41.37	29.45	12.58	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	496.40	14.23	1.64	2.19	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	449.82	15.20	13.75	6.88	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	403.91	16.73	9.61	3.56	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	1040.63	27.45	4.77	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	502.97	10.29	3.93	2.71	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	776.13	21.55	13.74	5.93	0.81
immature langerhans cells, donor1	11904-125F5	1045.59	14.53	7.26	6.30	1.45
immature langerhans cells, donor2	11905-125F6	830.15	27.72	20.60	5.54	1.58
insula, adult, pool1	10039-101F3	2746.17	49.78	28.39	24.60	3.03
keratoacanthoma cell line:HKA-1	10791-110H8	1058.68	25.69	26.01	9.10	1.30
kidney, adult, pool1	10017-101C8	2037.39	55.17	26.93	25.03	2.30
kidney, fetal, pool1	10045-101F9	837.16	16.13	7.71	7.22	1.20
large cell lung carcinoma cell line:IA-LM	10509-107D5	923.42	22.58	10.65	8.66	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	1019.12	30.27	15.90	9.40	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	377.09	15.41	11.93	7.52	0.73
left atrium, adult, donor1	10079-102A7	3758.93	85.00	40.32	43.59	5.45
left ventricle, adult, donor1	10078-102A6	2796.27	58.66	29.33	23.26	10.11
leiomyoblastoma cell line:G-402	10721-110A1	1164.76	43.50	29.55	17.51	4.65
leiomyoma cell line:10964C	10569-108B2	1165.40	38.80	20.84	15.09	2.51
leiomyoma cell line:15242A	10570-108B3	1253.81	44.57	14.67	13.59	0.54
leiomyoma cell line:15425	10571-108B4	1407.60	40.31	21.61	15.05	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	184.13	0.00	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	387.90	18.82	8.36	7.32	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	2317.60	22.19	30.81	11.33	3.07
liposarcoma cell line:KMLS-1	10782-110G8	716.38	22.03	10.47	8.44	1.09
liposarcoma cell line:SW 872	10726-110A6	799.14	26.32	12.43	9.26	1.58
liver, adult, pool1	10018-101C9	1555.14	68.71	30.79	27.71	3.24
liver, fetal, pool1	10086-102B5	780.79	17.87	11.29	5.64	1.88
locus coeruleus - adult, donor10196	10182-103D2	6314.35	129.64	222.38	57.45	13.85
locus coeruleus, adult, donor10252	10165-103B3	5073.67	129.55	680.44	86.92	11.07
locus coeruleus, adult, donor10258	10375-105G6	2824.77	124.14	260.70	35.83	11.29
locus coeruleus, newborn, donor10223	10362-105F2	6933.48	27.34	112.73	20.61	15.98
lung adenocarcinoma cell line:A549	10499-107C4	469.85	12.04	10.52	4.71	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	826.60	39.99	20.68	13.10	4.83
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	1163.67	27.55	17.27	11.07	2.50
lung, adult, pool1	10019-101D1	464.71	19.73	12.76	7.32	1.54
lung, fetal, donor1	10068-101I5	1172.17	17.70	1.14	6.28	0.57
lung, right lower lobe, adult, donor1	10075-102A3	2346.98	36.66	13.75	19.25	1.83
lymph node, adult, donor1	10077-102A5	1893.45	36.45	13.25	15.15	0.95
lymphangiectasia cell line:DS-1	10727-110A7	1241.64	30.47	23.89	10.74	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1249.07	22.19	13.28	4.98	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	784.93	11.04	4.25	4.25	0.00
mature adipocyte, donor1	12231-129F8	219.77	11.54	4.88	3.55	1.33
mature adipocyte, donor2	12232-129F9	308.39	13.49	5.81	3.94	1.25
mature adipocyte, donor3	12233-129G1	264.56	10.90	4.98	4.74	0.71
mature adipocyte, donor4	12234-129G2	295.59	13.42	3.95	4.47	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	1009.03	21.92	11.44	8.34	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	8957.69	86.86	212.07	20.30	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	7599.74	132.23	775.72	92.69	15.45
medial frontal gyrus, adult, donor10258	10368-105F8	7108.58	120.09	90.22	37.49	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	3132.55	8.10	328.82	5.54	7.68
medial temporal gyrus - adult, donor10196	10183-103D3	8457.96	190.69	242.66	79.48	13.67
medial temporal gyrus, adult, donor10252	10156-103A3	12306.06	212.86	1116.51	131.37	18.68
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	20907.62	86.68	46.23	40.45	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	158090.71	1909.03	861.22	444.96	57.41
medial temporal gyrus, newborn, donor10223	10353-105E2	1526.90	5.38	135.68	7.54	4.31
medulla oblongata - adult, donor10196	10174-103C3	5772.01	57.76	169.38	19.47	3.24
medulla oblongata, adult, donor10252	10155-103A2	4927.87	96.44	443.05	58.67	8.05
medulla oblongata, adult, pool1	10038-101F2	2223.85	45.87	21.96	19.10	2.37
medulla oblongata, newborn, donor10223	10361-105F1	1821.66	8.33	59.72	7.64	5.90
medulloblastoma cell line:D283 Med	10838-111E1	5110.19	84.36	46.28	34.98	3.76
medulloblastoma cell line:ONS-76	10759-110E3	741.10	17.61	15.28	7.09	1.10
melanoma cell line:COLO 679	10514-107E1	1052.08	19.98	18.40	6.61	1.01
melanoma cell line:G-361	10465-106H6	4062.71	108.31	47.78	34.48	3.26
meningioma cell line:HKBMM	10691-109F7	463.84	14.11	11.22	7.42	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	3889.43	145.39	53.75	55.51	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	2446.55	67.40	31.88	28.51	3.37
mesenchymal precursor cell - adipose, donor1	11747-123G1	895.60	22.25	9.21	12.27	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	914.18	26.72	7.09	11.82	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	1267.98	40.17	4.97	13.67	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	1078.29	25.85	6.18	12.64	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	903.15	21.95	7.90	11.17	1.93
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	1307.64	38.87	9.72	16.66	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	751.59	23.00	6.87	9.27	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	843.07	24.15	4.49	10.70	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	771.55	19.63	3.05	11.80	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	1286.26	33.22	11.34	19.04	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	960.13	24.04	5.12	10.53	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	1043.73	29.97	10.87	8.56	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	933.73	22.14	5.81	13.84	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	2376.56	59.34	22.69	22.69	3.49
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1144.14	27.15	4.49	12.45	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	1907.27	42.78	18.33	19.05	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	854.70	27.83	7.03	12.21	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2534.13	67.71	25.08	26.22	2.96
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	2026.04	49.09	5.87	27.69	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	910.97	23.61	6.28	11.06	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	1049.93	26.26	8.49	12.78	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	739.26	18.04	7.73	6.26	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	2655.25	55.80	17.17	21.75	2.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	2161.91	45.05	20.21	17.26	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	372.19	7.76	2.28	2.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	428.44	13.81	3.58	3.07	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	493.41	10.21	3.66	3.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	933.81	13.56	8.32	4.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	476.59	14.59	8.71	3.29	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	505.65	9.14	3.38	4.74	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	853.14	17.29	8.25	7.47	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	669.13	9.73	6.95	3.71	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	1207.59	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	591.54	15.86	4.90	4.33	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	547.49	6.47	4.91	2.90	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	625.64	12.02	4.33	3.61	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	254.46	13.20	6.60	4.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	600.15	6.38	7.38	3.36	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	644.77	9.83	4.91	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	565.30	12.89	5.15	3.01	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	391.02	21.88	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	1218.94	25.82	15.49	30.99	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	508.29	13.64	6.17	3.57	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	446.68	27.64	13.09	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	506.43	16.53	7.46	3.20	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	605.97	23.72	9.81	7.36	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	623.12	23.32	7.77	7.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	623.32	23.09	14.69	12.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	616.94	24.84	7.95	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	1449.24	61.97	19.07	23.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	477.93	20.75	8.30	4.74	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	394.78	23.15	6.09	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	324.63	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	411.07	21.54	5.70	5.70	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	308.34	13.45	3.45	7.24	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	677.00	21.49	12.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	1249.43	43.91	11.98	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	1921.69	48.21	17.22	13.78	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	961.63	19.15	11.00	4.07	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	891.36	18.27	11.12	7.15	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	858.35	24.17	19.45	7.66	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	592.86	10.29	3.74	2.81	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1034.59	33.42	12.03	9.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1868.62	33.11	22.47	10.64	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	3071.33	110.42	64.20	15.41	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	1612.22	42.68	14.46	6.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1946.57	49.48	28.70	9.40	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3259.10	63.93	37.01	29.16	6.73
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	2448.21	55.34	28.62	17.17	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1158.98	27.81	15.72	7.66	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2494.59	74.14	52.33	15.26	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1801.76	50.68	27.88	20.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	687.60	13.35	2.43	4.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	6240.70	167.20	103.94	36.15	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	2948.78	65.07	32.12	19.77	4.94
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	390.90	10.52	5.36	2.78	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	539.31	16.55	9.09	4.87	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	1681.75	39.73	29.54	16.30	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	38.69	1.55	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	399.72	14.88	10.63	4.25	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	933.18	23.40	21.55	12.28	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4568.47	38.46	25.64	21.37	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6740.83	183.92	109.43	65.86	7.60
mesothelioma cell line:Mero-25	10850-111F4	2002.19	25.87	12.03	11.35	1.13
mesothelioma cell line:Mero-41	10851-111F5	2234.99	31.54	10.76	11.00	0.98
mesothelioma cell line:Mero-48a	10852-111F6	3242.19	30.56	21.70	11.96	0.66
mesothelioma cell line:Mero-82	10853-111F7	5026.94	47.30	25.23	19.71	1.84
mesothelioma cell line:Mero-83	10854-111F8	4801.75	46.81	25.53	19.92	0.85
mesothelioma cell line:Mero-84	10855-111F9	1188.29	21.74	11.12	7.84	1.26
mesothelioma cell line:Mero-95	10856-111G1	1543.92	24.85	20.08	5.80	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	3420.63	34.62	13.75	16.56	0.83
mesothelioma cell line:NCI-H226	10846-111E9	3054.60	32.76	23.89	10.68	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	1848.81	25.11	17.42	9.91	0.51
mesothelioma cell line:NCI-H28	10845-111E8	3405.26	37.92	30.03	20.36	1.53
mesothelioma cell line:No36	10857-111G2	1357.00	19.57	16.31	4.89	0.33
mesothelioma cell line:ONE58	10858-111G3	1180.27	13.55	13.55	5.69	0.00
migratory langerhans cells, donor1	11901-125F2	1665.89	20.34	10.56	9.40	1.54
migratory langerhans cells, donor2	11902-125F3	743.32	12.21	7.33	3.79	0.73
migratory langerhans cells, donor3	11903-125F4	834.05	18.67	5.38	7.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	1292.53	61.38	33.95	20.57	3.59
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	781.83	26.70	17.59	7.63	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	447.58	18.43	9.44	8.06	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	820.92	21.69	17.32	6.66	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1310.18	24.39	13.49	7.21	1.29
myeloma cell line:PCM6	10474-106I6	636.49	18.98	15.22	6.72	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	459.10	45.15	10.65	19.78	4.57
myxofibrosarcoma cell line:NMFH-1	10684-109E9	1559.11	30.21	10.79	9.61	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	158.89	4.46	1.00	1.45	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	148.18	3.53	2.35	1.03	0.15
nasal epithelial cells, donor2	12227-129F4	234.04	2.76	4.42	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	1581.44	34.74	21.86	11.27	2.30
neuroblastoma cell line:NB-1	10539-107G8	1538.22	26.57	19.27	11.60	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	1881.13	45.34	14.34	17.29	1.48
neuroblastoma cell line:NH-12	10555-107I6	4842.89	90.75	66.90	35.59	3.17
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	5132.61	106.75	64.29	47.68	3.56
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1491.31	34.84	36.27	15.84	2.85
neuroectodermal tumor cell line:TASK1	10774-110F9	1191.86	14.69	15.90	5.84	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	825.86	47.05	13.99	19.71	3.18
neurofibroma cell line:Hs 53.T	10729-110A9	372.10	14.11	9.58	5.86	1.60
neutrophil PMN, donor1	12133-128D9	163.62	14.87	14.87	14.87	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1174.37	19.11	12.68	7.95	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	429.07	10.41	6.40	4.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	649.55	12.18	17.95	6.09	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	961.46	24.17	13.66	11.04	0.79
nucleus accumbens, adult, pool1	10037-101F1	2774.11	53.24	28.68	23.25	2.44
occipital cortex - adult, donor10196	10172-103C1	5946.27	57.69	451.22	22.66	4.12
occipital cortex, adult, donor10252	10163-103B1	12084.39	222.47	1000.19	138.48	15.30
occipital cortex, newborn, donor10223	10355-105E4	1253.42	5.10	123.38	5.46	4.00
occipital lobe, adult, donor1	10076-102A4	2164.53	167.41	40.93	43.56	7.35
occipital lobe, fetal, donor1	10073-102A1	2135.20	9.87	21.03	9.01	2.57
occipital pole, adult, pool1	10036-101E9	1368.06	26.65	14.59	11.12	1.42
olfactory region, adult	10195-103E6	7362.38	190.10	60.37	66.87	6.88
optic nerve, donor1	10277-104E7	2059.08	194.10	62.03	64.03	14.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	912.40	1.48	15.15	1.82	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1102.66	20.33	12.91	8.24	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	2142.96	42.33	18.29	19.64	2.37
oral squamous cell carcinoma cell line:SAS	10544-107H4	2142.69	40.66	26.80	17.90	1.27
osteoclastoma cell line:Hs 706.T	10704-109H2	485.93	15.58	6.76	7.94	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	190.60	21.49	5.61	9.34	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	1026.79	1.70	20.57	0.42	0.64
ovary, adult, pool1	10020-101D2	523.24	17.12	7.08	6.81	1.22
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	730.35	23.10	27.68	13.20	2.57
pancreas, adult, donor1	10049-101G4	1447.64	28.22	16.93	12.23	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1820.05	51.15	37.18	22.36	2.80
papillary adenocarcinoma cell line:8505C	10437-106E5	5856.23	122.31	48.72	53.32	4.26
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	661.67	11.26	9.11	4.47	0.50
paracentral gyrus, adult, pool1	10035-101E8	2485.37	49.97	29.29	22.15	1.46
parietal cortex, adult, donor10258	10373-105G4	10508.78	133.59	97.62	49.18	2.20
parietal lobe - adult, donor10196	10171-103B9	5889.31	72.42	80.88	36.68	2.82
parietal lobe, adult, donor10252	10157-103A4	9848.02	151.92	1009.32	112.87	19.38
parietal lobe, adult, pool1	10034-101E7	2093.55	41.77	21.68	18.24	1.41
parietal lobe, fetal, donor1	10072-101I9	8128.18	110.56	25.22	66.92	2.91
parietal lobe, newborn, donor10223	10356-105E5	1862.57	3.36	167.86	4.86	5.23
parotid gland, adult	10199-103F1	726.43	22.82	9.87	10.48	1.85
penis, adult	10200-103F2	3866.67	66.06	46.19	35.45	8.06
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	389.91	13.20	60.62	5.39	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	2705.11	57.84	44.44	23.46	2.19
pineal gland - adult, donor10196	10179-103C8	5425.33	83.85	79.98	26.45	6.45
pineal gland, adult, donor10252	10160-103A7	11240.19	90.02	189.51	50.93	4.74
pineal gland, adult, donor10258	10377-105G8	5232.31	100.96	110.37	28.85	3.14
pituitary gland - adult, donor10196	10180-103C9	5287.67	55.65	32.38	22.26	5.06
pituitary gland, adult, donor10252	10162-103A9	7553.98	54.72	66.19	34.92	5.21
pituitary gland, adult, donor10258	10378-105G9	9550.93	130.24	74.06	49.37	6.81
placenta, adult, pool1	10021-101D3	660.82	25.16	11.61	8.92	1.51
plasma cell leukemia cell line:ARH-77	10840-111E3	1377.24	36.42	14.83	10.99	3.18
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	404.20	22.72	9.65	6.23	0.62
pons, adult, pool1	10033-101E6	2557.92	50.78	28.40	23.93	2.58
postcentral gyrus, adult, pool1	10032-101E5	1781.87	43.24	23.54	20.40	2.53
promyelocytes/myelocytes PMC, donor1	12132-128D8	16.73	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	424.12	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	387.28	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	2536.70	46.03	35.98	19.96	2.04
prostate cancer cell line:PC-3	10439-106E7	1873.28	58.99	50.64	24.14	3.99
prostate, adult, pool1	10022-101D4	736.60	21.49	12.24	9.43	1.00
putamen, adult, donor10196	10176-103C5	7676.55	186.25	385.02	85.93	14.87
putamen, adult, donor10252	10152-102I8	6876.26	101.96	152.94	45.10	19.61
putamen, adult, donor10258, tech_rep1	10372-105G3	16889.37	93.98	38.25	29.51	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	11454.83	162.12	111.38	59.92	2.90
putamen, newborn, donor10223	10365-105F5	4087.90	10.50	59.97	14.24	6.00
rectal cancer cell line:TT1TKB	10469-106I1	867.28	36.66	38.11	17.75	3.20
rectum, fetal, donor1	10067-101I4	1350.65	65.38	30.60	13.91	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	1510.49	37.52	19.08	13.99	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	1031.38	30.65	28.17	16.57	1.24
retina, adult, pool1	10030-101E3	1675.97	35.29	18.59	15.41	2.09
retinoblastoma cell line:Y79	10475-106I7	2810.28	73.78	44.95	20.52	3.12
rhabdomyosarcoma cell line:KYM-1	10787-110H4	1650.46	4.92	16.35	4.67	1.97
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	2368.55	66.64	29.53	20.81	6.19
sacrococcigeal teratoma cell line:HTST	10695-109G2	581.27	26.52	8.34	11.37	2.27
salivary acinar cells, donor1	11771-123I7	2496.31	51.47	22.98	22.66	3.72
salivary acinar cells, donor2	11772-123I8	3655.46	59.48	26.85	24.51	4.68
salivary acinar cells, donor3	11773-123I9	2101.35	133.73	66.21	60.91	20.52
salivary gland, adult, pool1	10093-102C3	1593.46	45.76	6.86	12.01	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	1034.92	25.04	13.15	9.53	1.01
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	1197.38	26.57	24.57	12.11	1.65
seminal vesicle, adult	10201-103F3	1431.67	7.94	21.16	5.82	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	1751.73	49.80	21.62	17.73	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	402.61	9.06	4.03	2.01	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	2066.27	45.16	18.06	18.06	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	2651.49	46.21	28.34	21.89	2.01
signet ring carcinoma cell line:Kato III	10436-106E4	1260.79	27.96	11.05	12.93	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	1309.74	29.29	15.10	8.90	1.55
skeletal muscle - soleus muscle, donor1	10282-104F3	18185.93	632.73	285.15	294.37	45.40
skeletal muscle, adult, pool1	10023-101D5	798.78	43.90	20.15	16.67	3.24
skeletal muscle, fetal, donor1	10066-101I3	1594.96	3.02	17.09	3.02	1.01
skin, adult, donor1	10074-102A2	1078.85	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	1263.09	42.92	12.62	18.94	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	866.16	19.68	8.34	9.01	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8949.94	146.26	69.66	58.00	3.78
small cell lung carcinoma cell line:DMS 144	10841-111E4	1318.20	37.39	23.90	13.69	2.51
small cell lung carcinoma cell line:LK-2	10541-107H1	1994.41	27.69	29.17	12.86	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	2779.48	51.31	37.96	20.11	3.38
small cell lung carcinoma cell line:WA-hT	10562-108A4	3204.91	63.63	51.43	23.32	4.14
small intestine, adult, pool1	10024-101D6	1942.86	49.33	32.97	23.41	3.34
small intestine, fetal, donor1	10064-101I1	4254.23	65.60	21.62	27.52	2.70
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	3585.69	3.59	48.21	6.15	2.56
smooth muscle, adult, pool1	10048-101G3	2052.91	46.00	29.21	23.26	3.88
somatostatinoma cell line:QGP-1	10781-110G7	573.30	25.46	15.28	9.92	2.41
spinal cord - adult, donor10196	10181-103D1	3585.15	108.97	471.43	44.05	11.01
spinal cord, adult, donor10252	10159-103A6	4872.79	44.95	221.58	31.54	3.55
spinal cord, adult, donor10258	10369-105F9	10319.53	188.86	56.73	35.97	3.46
spinal cord, fetal, donor1	10056-101H2	2336.28	78.67	29.27	29.88	0.00
spinal cord, newborn, donor10223	10359-105E8	2721.75	10.10	84.50	11.48	9.18
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	649.54	24.64	16.28	8.66	2.09
spleen, adult, pool1	10025-101D7	561.79	15.86	10.13	8.26	0.88
spleen, fetal, pool1	10044-101F8	337.37	7.87	3.02	3.42	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	2467.73	54.86	33.64	19.67	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	961.72	38.17	21.84	16.14	1.90
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	5794.27	105.88	64.30	40.89	4.54
squamous cell carcinoma cell line:T3M-5	10616-108G4	1437.85	56.29	17.59	23.06	3.13
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1087.09	25.55	16.88	8.89	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1461.85	38.12	12.71	7.62	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	855.03	23.27	11.85	8.46	0.42
stomach, fetal, donor1	10062-101H8	625.83	44.85	28.84	17.09	4.27
submaxillary gland, adult	10202-103F4	1016.31	44.44	15.38	19.37	1.71
substantia nigra - adult, donor10196	10178-103C7	791154.33	10474.91	11126.20	2496.61	162.82
substantia nigra, adult, donor10252	10158-103A5	3400.35	88.69	331.91	50.26	7.27
substantia nigra, adult, donor10258	10371-105G2	8444.63	132.93	31.04	20.69	2.07
substantia nigra, newborn, donor10223	10358-105E7	2568.40	2.12	134.25	5.65	7.77
synovial sarcoma cell line:HS-SY-II	10441-106E9	2679.88	92.16	71.99	40.35	5.04
temporal lobe, adult, pool1	10031-101E4	2169.28	53.41	30.52	22.89	3.14
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2895.37	72.65	20.66	32.76	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	1380.15	44.83	11.87	15.82	0.88
tenocyte, donor1	11763-123H8	2459.76	34.21	16.41	15.36	0.70
tenocyte, donor2	11765-123I1	1366.93	28.61	11.45	9.54	0.38
tenocyte, donor3	11768-123I4	1556.42	30.77	11.49	11.86	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1763.51	36.71	26.17	16.66	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	1606.07	4.16	19.42	3.55	1.70
teratocarcinoma cell line:PA-1	10807-111A6	1281.82	17.20	12.09	5.58	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1252.21	21.58	13.84	10.28	2.41
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	3004.58	51.43	33.28	19.66	4.16
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	1627.97	52.46	12.98	24.21	1.64
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	4554.30	96.08	57.32	36.48	4.56
testis, adult, pool1	10026-101D8	565.64	21.69	11.27	12.13	2.04
testis, adult, pool2	10096-102C6	10825.59	169.61	44.21	64.05	4.96
thalamus - adult, donor10196	10168-103B6	9961.26	123.65	216.38	36.43	4.42
thalamus, adult, donor10252	10154-103A1	8355.04	137.37	648.11	101.27	14.69
thalamus, adult, donor10258, tech_rep1	10370-105G1	22593.89	93.92	50.81	20.02	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	8948.42	249.01	233.86	79.87	11.53
thalamus, newborn, donor10223	10366-105F6	2571.68	11.51	73.07	10.36	14.38
throat, adult	10209-103G2	905.30	51.43	20.97	18.73	2.25
throat, fetal, donor1	10061-101H7	1638.10	41.44	19.20	17.06	4.27
thymic carcinoma cell line:Ty-82	10803-111A2	5036.86	53.26	27.62	19.28	0.99
thymus, adult, pool1	10027-101D9	287.81	7.75	4.18	3.58	0.50
thymus, fetal, pool1	10043-101F7	390.89	9.56	3.43	4.16	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	1294.90	13.43	11.17	5.72	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	1448.59	26.68	29.61	9.08	1.12
thyroid, adult, pool1	10028-101E1	539.07	16.14	9.05	7.00	1.31
thyroid, fetal, donor1	10060-101H6	4085.46	83.05	65.92	30.58	5.80
tongue epidermis (fungiform papillae), donor1	10288-104F9	6319.37	240.21	135.50	73.91	33.88
tongue, adult	10203-103F5	1954.58	62.33	23.26	30.00	2.56
tongue, fetal, donor1	10059-101H5	2773.63	52.02	24.83	20.89	2.76
tonsil, adult, pool1	10047-101G2	678.19	14.22	7.61	6.11	0.80
trachea, adult, pool1	10029-101E2	631.89	17.18	8.75	7.28	0.57
trachea, fetal, donor1	10058-101H4	1916.55	48.47	21.54	14.23	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	1363.61	29.76	17.36	15.59	2.13
transitional-cell carcinoma cell line:5637	10418-106C4	665.65	15.91	7.60	5.07	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	1313.35	13.32	29.77	8.30	1.57
tridermal teratoma cell line:HGRT	10694-109G1	266.35	26.64	19.03	7.61	9.51
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1229.63	20.15	14.05	6.01	0.59
umbilical cord, fetal, donor1	10057-101H3	2714.54	50.08	35.47	27.12	4.17
uterus, adult, pool1	10100-102D1	1146.28	23.89	2.73	10.58	0.34
uterus, fetal, donor1	10055-101H1	680.86	19.45	10.75	7.17	3.07
vagina, adult	10204-103F6	1090.78	44.59	21.32	14.86	2.58
vein, adult	10191-103E2	730.37	22.58	10.30	8.11	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2154.72	39.52	20.83	14.15	1.34